introvivo reduces the amount of the virus in patients with hepatitis c infection . incivo is used for the treatment of chronic hepatitis c in adult patients ( aged 18 years and older ) who are already taking peginterferon alfa , ribavirin and telaprevir ( medicines called ns3 - 4a protease inhibitors ). incivo does not contain any of the ntr4a proteins that are normally present in hepatitis c virus . it is used in combination with another medicine called peginerferonalfa and ribavir . how incivo works incivo helps control the level of the
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo if you : - are taking peginterferon alfa or ribavirin . your doctor may need to adjust the dose of incivo or their contraindications ( e . g . pregnancy precautions ). incivo should not be used in combination with any other medicine containing the same active substance as peginerferon avfa and / or ribvirin . if you have any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg , 6 mg , 2 mg , 8 mg , or 6 mg twice a day . if you have both hepatitis c virus infection and human immunodeficiency virus infection , your doctor may prescribe efavirenz ( see section 2 " warnings and precautions "). your doctor should prescribe the right dose regimen based on how well incivo is working for you and how well it is affecting your body . incivo
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get an itchy skin rash . the rash is usually mild to moderate . other symptoms of the rash may include : - a severe skin reaction . if you notice a skin rash , seek medical help immediately . - swelling of lymph glands . - a wide - spread rash with peeling skin . - fever and flu - like symptoms . - painful skin blisters . blisters in the mouth , eyes , and / or genitals . if your rash gets worse , your doctor may stop your treatment immediately . contact your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special temperature storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture .
what incivo contains the active substance in incivo is telaprevir . each tablet contains 375 mg of teleprevir ( as besilate ). the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like
the active substance of zinbryta is daclizumab beta , a monoclonal antibody . what zinbaa is used for the active substance is dacogrel . how zinbenta works in patients with multiple sclerosis , therapy is usually followed by two ms treatment followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can be characterised by repeated attacks ( relapses ) and symptoms that affect your nerves . these
do not take zinbryta : - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have liver problems . your doctor may want to monitor you more closely while you are taking zin bryta . - you suffer from any other autoimmune disorders . tell your doctor or pharmacist if you are using , have recently used or might use any other medicines . this includes herbal supplements . you should not take any medicines that
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . if you have been told that your liver has not been working well enough , your doctor may decide to lower your dose to less than 40 mg . this blood test will be repeated every two weeks . if your doctor thinks that your dose is too low or too low , you may need to have another blood test
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems may occur very commonly ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( might affect up to 1 in 100 people ) severe inflammation of the liver may lead to death . tell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you need to use a new syringe / pen , or a refrigerator , please record the date on the label of the pen when you first start using it and the number of days it is stored at room temperature ( not above 30 ). once you have
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml solution for injection : each pref - filled pen contains either 150 mg or 300 mg daclzumab alpha . - the other ingredients ( excipients ) ( see section 1 ) are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) and water for injections . see section 2 for further information on some of the ingredients . what zinbaryta looks like and contents of the
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . wilzin works by attaching to copper from the intestine and its further accumulation in the body . this is thought to play an important role in the development and spread of the disease . the effectiveness of this treatment is not known .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . your doctor will monitor you closely during the treatment and may adjust the dose of blood and urine if sufficient treatment is required . monitoring 25 insufficient treatment ( copper excess ) may be necessary in case of excessive treatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . how much to take the recommended dose is 25 mg or 50 mg once a day . your doctor will tell you how many capsules of wilzin to take each day . the usual dose is 50 mg twice a day for 2 weeks . how to take wilzin 25 mg : 1 capsule each day for 1 week . wilzin 50 mg : 2 capsules each day after 2 weeks of taking wilzin . 25 mg dose : 1 to 6 capsules each morning for 1
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) very rare ( affects less than 1 users in 1 , 000 ) not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 people 10 , 000 not known : frequency can vary from very common to very rare . very rarely , very rare cases may affect fewer than 1 in ten , 000 people . wilzin intake
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ). each 50 mg hard capsule also contains 25mg of zinc , equivalent to 167 . 84 mg zincacetate diydrate . the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e133 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , capsule - shaped with wilzin 50 imprinted on one side .
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active substances are emtricitabine , an antiviral medicine ( also known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiireticiral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) in adults , adolescents and children . infection with h
do not take biktarvy if : you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety ). warnings and precautions talk to your doctor or pharmacist before taking bikarvy : if you have or have ever had liver problems . liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . you should also take aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " important information about these medicines "). if you take more biktarvy than you should if you accidentally take too many tablets , talk to a doctor or go to hospital straight away . patients on dialysis do not take bik
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur soon after hiv treatment is started . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that may have no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may occur many months after you start treatment . if you have any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg / ml of the active substance is bic tegravira , 200 mg / l of the other active substance are emptricitubine , ten ofovir aluminium fumarate equivalent to 25 mg/ ml of their active substances , and ten vonovir allafenide . - the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium
novondorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which a person either does not make enough insulin or does not respond normally to the insulin their body produces . when this happens , the sugar in the blood builds up and the body cannot use the insulin it produces normally . novonorm helps control the level of sugar in your blood . treatment is usually started with diet and exercise and weight reduction . your doctor will work out how much you should take each day . your blood
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a severe liver disease . - are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 - have liver problems . your doctor may need to adjust your dose of no vonorm . - have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take the tablet at about the same time each day . it is best to take it at least 30 minutes before or at least 4 hours after food . do not exceed the recommended daily dose of 30 mg for the first 16 days . your doctor may prescribe a lower or higher dose if your blood sugar is not controlled with
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm ( may affect up to 1 in 10 people ) is a hypo in section 2 . hypoemic reactions are generally mild / moderate . however , in some cases , hypoglycasemic unconsciousness may lead to coma . allergy allergy has been reported in very rare cases ( affects less than 1 user in 10 , 000 people ) with symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) only in 1 mg tablet and iron oxide red ( e 172 ) in 2 mg tablet only in 4 mg tablets only . what the tablets look like and contents of the pack noonorm tablets are 0 . 5 mg , 1 mg , 2
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . it is similar to a flu situation to that of ordinary flu . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who
pumarix should not be given : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse immediately . the vaccine may not fully protect all persons who are vaccinated . medical treatment may be needed in case of an
pumarix is for use in adults 18 years of age and older . pumarix contains a similar h5n1 as03 to those found in the blood . use in children and adolescents ( aged 18 years and older ) there is no information on the safety of this vaccine in children younger than 3 months of age . there are no data on the use in infants younger than 10 - 17 years . your doctor will decide on the best dose for you . how and when to give pumarx the vaccine is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure and shock . doctors are aware of this possibility and have emergency treatment available for use in such cases . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection has been fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the sachet in order to protect from light . after preparation of the suspension , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at ≤ 30 .
what pumarix contains - the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . - the other ingredients are haemagglutinin , which is used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 , which reduces the amount of the virus in the body . this adjuvvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants are used to improve the body ' s response to the vaccine . other ingredients in the suspension
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active ingredient in somakit to be used for this procedure is gallium , which is produced by recombinant dna technology in the manufacturing process . when the powder is mixed with the solvent , it can be injected directly into a vein or into the body areas . this is a medical imaging procedure called positron emission tomography ( ptom ) ( pet scan ). the purpose of this medical procedure is to obtain images of the abnormal cells and
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you experience any signs of allergic reaction ( see section 4 ) if you think any of these apply to you , or if you have been in close contact with someone who has , or has had , kidney or liver problems . if you suffer from renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years of age because of the risk of dehydration .
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . 29 the nuclear medicine doctor supervising the procedure will decide the quantity of somakttoc to be administered . the usual dose is between 100 mg and 200 mg megabecquerel per kilogram of body weight each day . if you have the impression that the effect is too strong or too weak
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakit : allergic reactions ( hypersensitivity ) have been reported following the administration of somakiton to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also report side
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : somakit t will be stored in a refrigerator ( 2 - 8 ). storage at room temperature ( up to 25 ) does not require any special temperature storage conditions . do not freeze . store in the original package in order to protect from light . the product should be used immediately after dilution . if not used immediately , in - use storage times
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - the solution contains hydrochloric acid which is used to adjust the amount of radioactivity in the vial ( see section 2 ), and is used for radiopharmaceutical preparation . what it looks like and contents of the pack the medicine is a glass
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women . it belongs to a group of medicines called non - steroidal aromatase inhibitors , which are used to keep the disease under control . it is used in combination with a medicine called exemestane ( a steroid aromatase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels , lung or panc
you must not be given afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before you are given any of the following : - if you have everolimus , sirolimus , or temsirolamus in the form of this medicine . if you think you may be allergic , ask your doctor for advice . - if any of these apply to you , tell your doctor before you receive afincer . - you have or have had any problems with your liver , or any disease affecting your liver . your doctor may prescribe a different dose of Afinitor . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . if you take more afinitor than you should if you have been told you have liver problems , your doctor may prescribe a lower dose of Afinitor ( between 5 mg and 5 mg ) or a higher dose of 7 . 5 mg . in order to reduce the risk of certain side effects your doctor will monitor you more closely during treatment . how long to take keep taking afininitor until your doctor tells you to stop . if
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps if you notice any of these , stop taking the medicine and contact your doctor immediately . the following side effects have been reported with the combination of the two active substances of afincer : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . open the blister and remove the tablets from the blister only directly prior to intake . never take this medicine if you notice any visible sign of tampering or if the tablets are damaged or have any visible signs of tampering other than a marked " exp ". do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
what afinitor contains - the active substance is everolimus . - each tablet contains either 2 . 5 mg or 2 . 75 mg of everlimus ( as besilate ). - the other ingredients are : - tablet core : alfentanil . - tablet coating : amylhydroxytoluene ( e321 ), magnesium stearate ( e470b ), lactose monohydrate , hypromellose ( e464 ), crospovidone ( e1201 ) and lactose anhydrous ( see section 2 under ' important information about some of the ingredients '). what af
what laventair ellipta is and what it is used for the active substance in this inhalation is umeclidinium bromide and vilanterol . this belongs to a group of medicines called bronchodilators . what lavent air ellipta looks like and contents of the pack this medicine is a clear , colourless to pale yellow inhalation that is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have asthma . this medicine should not be used in patients with asthma . - have heart problems or high blood pressure . - had an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - have epilepsy , thyroid gland problems , diabetes or severe
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . do not use more than your doctor tells you to use . use laventair ellipta every day , as instructed by your doctor . it is important that you use it every day and not only when you feel better , but also when you have symptoms such as : a sudden attack of breathlessness or wheezing . if you get this sort of attack
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you experience immediate breathing
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms of umclidinnium ( equivalent to 65 microlitres ) of umaclidoidiniumbromide , and 22 microspectrombocrit ( microgrambochetate ) of vilterol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what lavent
the active substance of tremfya is guselkumab , which is a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis in adults and children . it is used in adults who have moderate to severe " plaque psORiasis " which is an inflammatory condition that affects the skin and nails . it can improve the condition , the appearance of nails , and reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have an active infection or active tuberculosis warnings , precautions , and precautions before you receive tremfaya , tell your doctor or pharmacist if you : have an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening , group of conditions in which patients 36 develop an infection .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) injected under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will decide how many treatments you need and how often you need to use it . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : signs of serious allergic reaction such as difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common side effects (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains large particles . if the liquid is discoloured , it should be thrown away from the refrigerator and returned to the refrigerator . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml of solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . see end of section 2 for further information about some of the ingredients . what tremfa looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution , supplied in a carton pack containing one single - dose glass syringe and
the active substance of trepulmix , treprostinil , belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels , thus preventing them from clotting . trepanmix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients whose condition is persistent or recurrentcteph . it is used either alone or in combination with surgical treatment to improve exercise capacity and reduce symptoms of the disease . the most common problems in patients with ctph are : high blood pressure is too high , which affects the
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease which causes the blood vessels in the lungs to become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have a heart problem . have had a heart attack ( myocardial infarction )
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( injection under the skin ) into a small tube ( cannula ) in the upper abdomen or thigh . you will be given one or two doses ( 1 mg , 2 . 5 mg , 5 mg and 10 mg ) at a time . the rate of infusion will depend on your condition and will be adjusted by your doctor . your doctor may need to adjust the infusion rate depending on the severity of your condition . special dose adjustments if you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction . this may be the case for a small number of patients . tell your doctor straight away if you notice any of the following : signs of the infusionsite bleeding or bruising at or near the infusion site : headaches , nausea , diarrhoea jaw pain common : dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . a trepulmix vial may be kept at room temperature ( up to 30 ) for continuous subcutaneous infusion in a single vial or a single reserve ( syringe ) of undiluted turbulmix for a maximum period of 72 hours . the hospital staff will ensure that this medicine is used correctly and not causing damage , discolouration or other signs of deterioration
what trepulmix contains - the active substance is treprostinil ( as sodium ). each vial contains 1 mg / ml of solution for injection . each 2 . 5 ml ampoule contains 10 mg of solutionfor injection . - the other ingredient ( s ) ( excipients ) ( isminutinil ) and sodium salt ) ( see section 2 ). each 3 . 5 millilitre ampoules contains 2. 5 mg of preparation for injection and 10 mg or 25 milligrams ( 0 . 5 mg ) of treprosticinil in the form of sodium salt . each 5
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the recommended dose of thorzinane is 1 milligram per kilogram body weight , to prevent existing blood clots from forming . your doctor will prescribe the lowest dose ( 2 milligrams ) for you , depending on how you respond to the treatment . the main aim of stoppingblood clots forming in your blood is to reduce the risk of having them during or after an operation . if you have an acute illness called unstable angina . if your heart is not working properly .
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), tell your doctor straight away . a reaction with either of these active substances can lead to a severe drop in the number of your clotting cells ( plate
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . if the bleeding is severe or if you experience any bleeding event that does not stop immediately , including exceptional weakness , tiredness , paleness , dizziness , headache and unexplained swelling , stop taking your medicine and contact your doctor immediately . if you are not sure , talk to your doctor , pharmacist or nurse before you take your medicine . tell your doctor or nurse straight away if you have : - a severe allergic reaction , difficulty breathing , swelling of the lips , mouth , throat or eyes ( signs of blockage of a blood vessel
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 . after dilution the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2ºc - 8ºc . this medicine is for single use only . the thorinane pre - filled syringes should be disposed of in accordance with local requirements .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in 0 . 2 ml solution . after dilution , each ml contains 2 , 000 mg ( 4 . 0 mg / ml ) deoxapar sodium in solution . the other ingredient is water for injections . what the solution looks like and contents of the pack the solution is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . each carton contains
senstend contains two active substances : lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , helping to control the rate of ejaculation .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have a history of allergy or sensitivity to local anaesthetics ( see section 4 ). if you know that you are being treated with amide - type local anahetics . if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), such as anaemia ( methaemoglobinaemia ). medicine sensitivities
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 1 spray in each head of your penis ) once a day for 24 hours ( see section 4 " how to use senstends "). use the spray container immediately after removing from the pump mechanism . avoid direct contact with eyes , nose , mouth and ears . after using the pump , 1 spray into the foreskin of your head , inside your penis , through the valve ( picture 1 ). 3 spray into your head and into
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with senstend : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( might affect up to 1 in 100 people ) headache local irritation of the throat or irritation on the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort when the penis itching when the area around the penis is exposed to a high temperature other side effects include : common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . store below 25 for a maximum period of 12 months . keep the container tightly closed in order to protect from moisture . after first opening of themetal container , do not puncture or burn the container . write down the date of opening on the container label and the date after which the container should be discarded . store in a refrigerator ( 2 - 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms lidocain ( equivalent to 50 microlitres ) in each ml . - the other ingredients are : prlocaine 50 microgram : each spray delivers 7 . 5 microgram of lidocane ( corresponding to 2 . 5 milligrams ) in the each ml , and is for oral use only . - each spray container contains either 6 . 5 ml or 20 ml . each spraycontainer contains 5 to 12 ml of light yellow cutaneous spray . - an aluminium spray container
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in opdivo , nivolumab , is a mon
do not take opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given opDivo if : - you have problems with your heart such as a change in the rhythm of the heartbeat or an abnormal heart rhythm . - your lungs have breathing difficulties such as cough . - inflammation of the lungs ( pneumonitis or interstitial lung disease ). - you get diarrhoea , watery , loose or soft stools , or any symptoms of inflammation of any intestines (
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take adults the recommended dose for adults and children weighing at least 240 kg is one 240 mg tablet once a day ( corresponding to 2 x 480 mg per kilogram of your body weight ) for 4 weeks . the dose for children weighing less than 40 kg will depend on the type of skin cancer that you are being treated with . your doctor will prescribe the dose that is right for you . the recommended dosage for adults is one 1 mg tablet of nivolumab per
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours after reconstitution . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 25 mg of 24 mg ( as 300 mg of 30 mg ). - the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 " opDivo contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections
clopidogrel tad contains clopridogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process known as thrombosis ). clopidogsreltad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombinosis , which can lead to atherotrombotic
do not take clopidogrel tad : if you are more than 30 years of age . if you think you may be allergic , or are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopridogrelTad if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you suffer from severe liver disease . if any of these apply to you , tell your doctor or pharmacist . take special care when you are being treated : you may not be fully effective at controlling the level of bleeding if :
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( up to 300 mg once a day ), such as one 300 mg tablet , as long as you continue taking cl
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel tad contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc andmacrogol 3000 in the film - coating . what clopIDog
tacforius contains the active substance tacrolimus , which is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius is used to prevent rejection of transplanted organs by the liver , kidney and heart after any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide , antibiotic , erythromycin , clarithromycin or josamycin . warnings and precautions talk to your doctor , pharmacist or nurse before you are treated with tacvorius immediate release capsules ( e . g . tacni ). tacforia prolonged - release capsules should not be used in combination with any other medicine . tacvorus can be taken with tacro
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor who is experienced in the use of this medicine . transplant patients should take the same tacrolimus medicine as adults . if you have had a transplant , your doctor will prescribe a different tacrolemus medicine . you should continue taking this medicine until your doctor tells you otherwise . this is to make sure that you are taking the right medicine to prevent the rejection of your transplanted organ . dose the dose you take will depend on your body weight . the
like all medicines , this medicine can cause side effects , although not everybody gets them . infections tell your doctor or nurse straight away if you notice any of the following serious or potentially life - threatening infections while you are being treated with tacforius : severe effects including allergic and anaphylactic reactions , benign and malignant tumours have been reported in patients treated in the post - marketing phase of ticforius treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), haemolytic anaemia (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after first opening the aluminium wrapping , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains - the active substance is tacrolimus . each hard capsule contains 0 . 5 mg . each prolonged - release hard capsule releases 1 mg ( 3 mg ) of tacrulimus ( as monohydrate ). each capsule releases 2 mg ( 4 mg ). - each capsule release 3 mg ( 6 mg ) contains 3 mg of tacrolamus (as monohydrate ) . each capsule released 5 mg ( 5 mg ). the other ingredients are : capsule content hypromellose 2910 ( e464 ), ethylcellulose , lactose , magnesium stearate . in capsule shell tacfor
clopidogrel zentiva belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombolybosis ). clopidoggingrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombosis , which
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to the active substance clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer , bleeding within the brain or severe liver disease . if this applies to you , tell your doctor . warnings and precautions the following apply to you and your doctor : if you take any other medicines while you are taking clopridogrelzentiva ( see section 4 ): -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose of 300 milligrams ( one 300 mg tablet ) once a day for 4 weeks followed by a 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . clopidogrel zentiva is for single use only . aluminium blisters : do not store above 30 . store in the original package in order to protect from moisture . keep the blister tightly closed in order for the medicine to reach room temperature . bottle : keep the bottle tightly closed . tablet : after first opening of the bottle , do not remove the bottle until it is ready to
what clopidogrel zentiva contains - the active substance is clopidoogrel . each tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are ( see section 2 under ' important information about some of the ingredients in clopidiogrelzentiva '): - tablet core : lactose ' ( as hydrolysed ), - tablet coating : mannitol ( e421 ), hydrogenated castor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate (
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . it is stored in the original package in order to protect from light . the product is used in combination with another medicine for tiny radiation doses . the treatment is a radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you are pregnant , think you may be pregnant or are planning to have a baby . - your doctor will decide if you should be given the medicine . - you have not been previously vaccinated . - the safety and efficacy of the product has not been established . - it is not known if it passes into the blood or if it contains traces of radioactive
your doctor will supervise the treatment . method of administration yttriga is for radiolabelling of medicinal products for specific diseases . your doctor will decide on the appropriate dose for you . the treatment will be supervised by a physician experienced in the diagnosis and treatment of overdose and will be overseen by a doctor who is experienced in appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances are in place to protect the environment . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). the vial consists of a v - capped bottom and a colourless type i glass vial containing 10 ml with a flat bottom , with a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . the active substance in ciambra , cisplatin , is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , when no other treatment has been available or patients have not received prior chemotherapy . in this case , cimbra will be given to you in combination with cisplin for the initial treatment . if you have lung cancer that has come back after a long and steady period of time , your doctor may decide to give you ciam
you must not be given ciambra : if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you are breast - feeding . during or after treatment , you should not breast - feed while you are being treated with this medicine . you have recently received or might receive a vaccine against yellow fever . your doctor may decide to delay or discontinue your treatment with cinembra . if you have or have had problems with your kidneys , your doctor
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of the body . your doctor will work out this body surface area based on your weight and height and will adjust your dose of treatment depending on your blood cell counts and on your general condition . the infusion will last approximately 9 to 9 hours . sodium chloride solution will be given to you by your doctor or nurse before you are given ciamBra . it is given by infusion into one of your veins . it will take approximately 30 minutes for the infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor straight away if you experience fever or infection ( with a temperature of 38ºc or greater ), sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you have chest pain ( with or without a fast heart rate ), pain , redness , swelling or sores in your mouth ( signs of allergic reaction ), skin rash ( often with burning or prickling sensation ), fever . skin reactions may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion solution of pemetrexed should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 and 15 to 25 . the reconstituted solution should be administered immediately after preparation . if unused , the infusion mixture should be stored in a refrigerator
what ciambra contains the active substance is pemetrexed . each vial contains 100 mg / ml of solution for infusion , corresponding to 100 mg of pemdesed ( as pemetreed disodium hemipentahydrate ). each vials of ciamra 500 mg / m2 contains 500 mg of solutionfor infusion , according to the dose prescribed by your doctor . the other ingredients are : powder : mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hydroxide ( e524 ) ( e507 ), water for injections ( see section 2 " ciam
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam works by preventing certain infections from getting in and out of your blood . your doctor will test your body for increased levels of human hepatitis b immunoglubulins , immunoglobin g ( igg ) and blood plasma of screened patients . immunogogam is used to treat hepatitis b virus in haemodialysed patients who have not received vaccination . antibodies against a hepatitis birus carrier may result in an immune response and the development of measurable hepatitis b antibodies . vaccination is a type of continuous prevention
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). if you suffer from an iga deficiency . - if your doctor has told you that you may have an allergy reaction to iga containing products . children and adolescents ( from 18 years of age ) who have not been treated before and who do not respond normally to immunogloglobulin . signs of adverse reactions include chills , headache , fever and vomiting . allergic reactions may include nausea (
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). dosage and administration prevention the recommended dose of hepatitis b is 500 micrograms given every 24 hours for up to 72 weeks . your doctor will decide on the dose that is right for you . the recommended recommended dose is hepatitis b in haemodialysed patients of 500 iu / kg body weight given every 2 weeks . seroconversion following vaccination is recommended .
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very rare ( affects less than 1 users in 1 , 000 ) rare : very rare : may affect up to 1 in 10 , 000 not known : frequency cannot been estimated from available data . if any of the undesirable effects gets serious , or if you notice any side effects not listed in this leaf
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . immunogogam should not be used if the solution is cloudy or contains deposits . medicines should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one vial contains 1 mg or 5 mg of human plasma protein , corresponding to a concentration of 96 micrograms / ml . - the other ingredients are polysorbate 80 and water for injections ( see section 2 ). what immunogams looks like and contents of the pack immunogamer is a solution for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each carton contains 1 vial of immunogamation .
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called 'tnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis . you have been prescribed remicades by your doctor for the treatment of 6 diseases :
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of the medicine ( listed in section 6 ) - if your doctor thinks you may be allergic ( hypersensitive ) to the active substance . warnings and precautions talk to your doctor if you have ever had tuberculosis ( tb ) or another serious infection , e . g . pneumonia , sepsis or heart failure . if you think you may have been in close contact with someone who has had this problem , ask your doctor for advice . if any of these apply to you ( or you are not sure ), talk to
what remicade is used for the treatment of : rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual starting dose is 5 mg for each kg of weight . your doctor will decide how many treatments you need . how remicades is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . tell your doctor or nurse straight away if you notice any of the following side effects during or after your treatment with remicade : signs of an allergic reaction include swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild and disappear within a few days . if you experience signs of another allergic
remicade will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution , chemical and physical in - use stability has been demonstrated for 2 to 8 hours at 25 mg / ml . remicade may be used for infusion for up to 3 hours at 2 - 8 , followed by 28 hours at room temperature ( 20 - 25 ) for an additional 24 hours at
what remicade contains - the active substance is infliximab . each vial contains 100 mg of inflixamab . after reconstitution , each ml contains 10 mg / ml of solution for infusion . - the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for injection or infusion . the powder is white to off - white and the solvent is a clear colourless liquid . remic
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine that is used for the treatment of parkinson ', s disease ). with parkinson's disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical that helps the brain to work properly , especially in tasks such as movement control . rasagilinea mylan increases the amount of dopamine that can be produced in your brain .
do not take rasagiline mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . - medicinal or natural products containing st . john ' s wort . - pethidine , a strong pain killer . see section 14 for further information . if you think any of these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet ( 1 mg ) taken by mouth once daily . take rasagiline mylan at the same time each day . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth
what rasagiline mylan contains - the active substance is raspiline . each tablet contains a single milligram of rasagailine tartrate ( equivalent to 1 mg rasgailine ). - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize starch ), talc , stearic acid . see section 2 for further information about some of the ingredients of this medicine ( see section 4 ) and other ingredients of the tablet core ( see " raspildine melan contains lactose "). what r
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection such as tuberculosis ( see section " warnings and precautions "). symptoms of infections may include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . if any of these apply to you , tell your doctor . allergic reaction : allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years of age weighing 10 kg or more the usual dose is 30 mg once a day . hulio is available as 20 mg twice a day ( 1 tablet in the morning and 2 tablets in the evening ). children and teenagers from 2 - 17 years old weighing less than 30 kg the usualdose is 40 mg once daily . for enthesitis - related arthritis in infants from 6 to 17 months old weighing 15 kg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak
what hulio contains - the active substance is adalimumab . - the other ingredients are : monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . see section 2 for further information on the contents of the pack hulios 40 mg is a sterile solution for injection in a vial . each vial contains 40 milligrams of adlimumab in 0 . 8 ml of solution . the solution is clear and colourless to slightly opalescent . the vial is closed with a rubber stopper . h
what yellox is yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) which reduce inflammation . what are yellox used for ? it is used to treat eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using yellox if you have asthma , skin allergy or intense inflammation in your nose . you should not use other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine should not be used in combination with topical steroids such as cortisone , as it may increase the risk of unwanted side effects .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in the affected eye ( s ) once a day . if you use more yellox than you should if you accidentally use too many drops , contact your doctor , pharmacist or nurse immediately . use the drops within the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down ,
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . it is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dzuvoo if : you have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ) that you can ' t control or have not controlled before you start treatment . you have recently had a head injury or brain tumour . your doctor may want to monitor your heart and circulation more closely
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a glass of water . do not chew , crush or break the tablet before swallowing . you can take dzuveo with or without strong painkillers such as sufentanil . the recommended starting dose is 30 mg once a day . the sublingual tablet should be taken orally with a sufficient amount of food . use the disposable single -dose applicator provided in the pack . insert the applicator into
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems , especially slow and shallow breathing . stop taking dzuveo and see a doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side side effects that may affect up to 1 in every 10 people : - inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . after first opening , the product should be used immediately . this medicine does not require any special temperature storage conditions . if you notice any visible signs of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . the tablet is white to off - white and has round edges . each carton contains 3 tablets . each pack also contains a single - dose applicator ( labelled [ sublingual tablet ]). the applicator contains one suf
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it also helps to prevent sensitive prostate cancer from returning to the body after surgical treatment . it reduces the levels of testosterone in the blood in men with resistant prostate cancer . erleada also blocks the effects of androgens , which are involved in the growth and spread of the cancer . by blocking the effect of both androgens in men who have been previously treated with androgens ( a type of hormone produced by
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine may cause seizures . tell your doctor if you take , have recently taken or might take any medicines that may increase the risk of blood clots ( e . g . warfarin , acenocoumarol ) if you have any heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 240 mg twice a day . your doctor may increase your dose to 60 mg once a day depending on how you respond to erleada . taking this medicine by mouth is the best way to reduce the risk of side effects . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . taking other medicines please tell your doctor if you take , have recently taken or might take any other medicines . do not take er
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the most common side effects are fits ( seizure ) which may affect up to 1 in 100 people
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of appalutamide ( as mesilate ). - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose ( e460i ), silica . - the film - coating contains iron oxide black , iron oxide yellow ( e172 ), macrogol , polyvinyl alcohol ( e1203 ), talc , and titanium dioxide ( e171 ). what erle
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out scan ( a pet scan ) in adults who have previously had treatment for prostate cancer and who have had other tests to check prostate specific antigen ( psa ) ( the type of protein that carries the cancer ). an axumin pet scan can help your doctor determine whether the cancer has responded to treatment . the scan will be done under the supervision of a doctor who is experienced in the use of this type of medicine . your doctor and the nuclear medicine doctor have considered that the clinical benefit of ax
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin if you have kidney problems . you must follow a low sodium diet . axumin is given once a day for the duration of the axumin scan ( see section 4 for more information ). during the scan , you will be given your usual medicines to take during the latest 60 minutes before and during the 60 minutes after you have been given it . you may need to take a short break after the
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used in each case . the usual dose is 370 megabecquerel per kilogram of body weight . how axumin is given for the procedure axumin must be injected into a vein by a flush of sodium chloride
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . uncommon ( affects 1 to 100 users in 1 , 000 ) the side effects of axumin were mild to moderate and occurred in less than 1 in 100 users . however , pain , rash , altered taste in the mouth and altered sense of smell were reported . this radiopharmaceutical will deliver low amounts of ionising radiation which may increase the risk of cancer and hereditary abnormalities . reporting of side
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( equivalent to 1600 mg or 16000 mg ). axumin 3200 mg / ml : each millilitre ( 0 . 3 ml ) contains 3200 micrograms ( 1 . 5 milliliter ) flucIClovine 3200 - 32000 mg : the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents of the pack
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems . if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some people : if you develop too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor before you take
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the affected eye each day . do not use azopt in both eyes at the same time each day ( see section 1 , 2 , 3 ). take the azopt bottle with you . wash your hands before using it . remove the cap . the cap can be removed with a snap collar . hold the bottle tightly with your thumb and a finger . tilt your head back . pull down your eyelid with a clean finger
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other possible side effects : bad taste . uncommon side effects - effects affecting more than 1 in 100 people ( frequency cannot be estimated from the available data ): sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of brin zolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap .
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines ( medicines taken by mouth ) used to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to treat the following diabetes types : type 1 diabetes : your body does not make enough insulin to control the level of sugar made in your body . this is called ' sugar - free ' diabetes . you are overweight ( obese ) or have type 2 diabetes . your body hardly makes enough insulin , or the insulin that your body makes does
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking for xiga if you : - experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a sweet or metallic taste in your mouth , a different odour to your urine or sweat , or rapid weight loss . contact your doctor straight away if you experience the above symptoms .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of forxiga for type 2 diabetes is one 10 mg tablet once a day . your doctor may increase your dose to a maximum of one 5 mg tablet twice a day if you have a liver problem . how to take your dose depends on your body weight and how you respond to the medicine . for example , your doctor will prescribe a lower dose for type 1 diabetes in the morning and a higher dose for 5 mg in the evening . taking this medicine swallow the tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : angioedema ( rare , may affect up to 1 in 10 , 000 people ): angioEDema may cause swelling of the face , tongue or throat which may cause difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( rare ), if you have type 1 diabetes ( very common , affects more than 1 user in 10 ) or type 2 diabetes ( uncommon , affects 1 to 10 users in 1 , 000 ) these are the signs of
what forxiga contains - the active substance is dapagliflozin . eachforxiga 5 mg film - coated tablet ( tablet ) contains a single tablet called ' dpaglifllozin propanediol monohydrate equivalent to 5 mg of dapglifloin '. - the other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 ' for important information about lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350
mifamurtide works by stopping the growth of certain bacteria which are resistant to the immune system . mepact is used to treat adult patients with osteosarcoma ( bone cancer ) that has spread between 2 and 30 years after surgery to remove the tumour . it is used in combination with chemotherapy which stops cancer cells from growing and cancer is likely to come back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you are taking medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ) - you have problems with your heart or blood vessels such as blood clots ( thrombosis ) - bleeding ( haemorrhage ) - inflammation of the veins ( vasculitis )
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults the recommended dose of meepact is 2 mg mifamurtide once a day for 12 to 24 hours . your doctor will tell you how many of your mepact treatments you need to take . this will depend on your chemotherapy schedule and on how you respond to your chemotherapy . the usual dose is 36 mg / kg body weight twice a day . how to take treatment with mepacts
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very commonly in patients receiving mypact ( transient use of paracetamol ). if you experience fever during or after treatment with treatment , you should contact your doctor immediately . stomach problems ( nausea and vomiting ) and loss of appetite have also been reported during chemotherapy . tell your doctor or nurse immediately if you have continuing fever or chills . children and adolescents 8 years of age and older and weighing less than 25 kg have been treated with mepacts . signs of an infection such as rash
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial in outer carton and on the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 hours . do this medicine if you notice any visible signs of deterioration . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg ( 0 . 07 mg ) of mifamate . - the other ingredients are 1 - palmitoyl - 2 - ol - sn - glycero - 3 - phosphocholine ( see end of section 2 ) 2 - dioleoyl , sn - gglycero- 3 - phosphate - l - serine monosodium salt ( e211 ) see
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . mirvaso is used on the skin and in the face to reduce redness associated with rosacea ( redness of the face ) and to reduce the number of redness at the site of application . the most common complication of rosinacea is high levels of blood flow in the facial skin , which can lead to enlargement ( dilution ) of the small blood vessels of the skin . by blocking the blood vessels , the product prevents the excess blood flow and reduces redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the medicine should not be injected under the skin . certain medicines used to treat depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as maprotiline
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso should only be applied to the skin on the face . this medicine should not be injected into any other part of your body . if your body surfaces , such as your eyes , mouth , nose or vagina , do not use more than once a day . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . how much mirvasos to use the recommended dose is one tablet twice a day ( one tablet in the morning and one tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . the treatment should be stopped immediately if symptoms persist ( see section 2 " warnings and precautions "). contact allergy allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if any of these apply
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each millilitre of gel contains 3 . 3 mg ( 5 mg ) of bromonidine tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 under " miraso contains methylparhydroxy benzoate "), propyleneglycol , water for injections . what mirvasoa looks like and contents of the pack the gel is a
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body from infection and cancer by blocking the activity of a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of lymph vessels and other parts of the body where it stimulates the vein gf protein ( a substance that allows blood vessels to expand and provide them with oxygen ). by blocking this protein , bev
you must not be given this medicine : if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you ( or your child , if they are allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products ( see section " other medicines and mvasi "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this type of medicine if you : have a history of developing holes in the gut wall caused by inflammation inside the abdomen ( e . g . diverticulitis
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . the dose may be increased or decreased by your doctor depending on the severity of your condition and the number of infusions you receive . your doctor may increase your dose or decrease your dose depending on how you respond to treatment with this medicine . if you have the impression that the effect of the medicine is too strong or too weak , talk to your doctor or pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : tell your doctor or nurse straight away if you notice any of the side effects listed below . these effects are usually mild to moderate and usually go away after a few days of chemotherapy . these side effects can be serious and need immediate medical attention . stop using mvai and see your doctor straight away . allergic reactions if you have an allergic reaction , including difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution , chemical and physical in - use stability of infusion solutions has been demonstrated for 24 hours at 2 to 8 oc . from a microbiological point of view , the infusion solutions should be used immediately . in a sterile environment , dilution should be performed in accordance with local requirements . in this case , the product should be stored in a refrigerator ( 2 - 8 )
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg of bebacizumaab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the other ingredients ( excipients ). - the other ingredient ( s ) are : tablet core : amylose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasoi looks like and contents of the pack mvasis is a concentrate for solution for infusion . it is a clear to slightly yellow liquid supplied in
tecartus is a gene therapy medicine used to treat mantle cell lymphoma in adults . it is used in combination with other medicines for the treatment of refractory mantle cancer . tecartus contains your own white blood cells ( called autologous anti - cd19 - transduced cd3 + cells ). mantlecell lymphoma is a cancer that affects the immune system ( the body ' s natural defences ). it is caused by the lack of b - lymphocytes which are involved in the growth and spread of the cancer . in adult patients , the number of these cells is much higher than in normal people . mantle cell
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : you have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ) you have an abnormality of a certain number of these types of white cells ( autologous use ). your doctor will carry out tests ( checks ) to check your lungs , heart , kidney
tecartus consists of your own white blood cells . your cells will be collected and given to you by a doctor or nurse through a catheter placed in your vein ( a procedure call leukapheresis ). the number of these cells will depend on the type of medicine being prepared and how well your cells are working . tecartus is given by infusion into a vein ( intravenous use ). it is given every 3 to 6 weeks . the number and number of your white blood cell will be reduced over a period of 2 to 3 weeks . your doctor will decide how many treatments you need . medicines given before tecart
like all medicines , this medicine can cause side effects , although not everybody gets them . if your side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or nurse . you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 ml . this medicine contains genetically modified human blood cells and human - derived material . after dilution , the product should be used within 36 hours .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - cd19 car t cells in approximately 68 ml ( corresponding to 2 x 106 anti ) cells . - the other ingredients are sodium chloride and human albumin ( see section 2 " important information about some of the ingredients of tecartu ") - the concentrate for solution for infusion is reconstituted in an infusion bag using a metal cassette . a single infusionbag contains 68 ml of cell dispersion .
januvia contains the active substance sitagliptin which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your condition . januvia can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas
do not take januvia : if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking januuvia if : you have ( in section 4 ) blistering of the skin ( bullous pemphigoid ) if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist as soon as possible before taking this medicine . you have or have ever had : a disease of the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue taking this medicine until your doctor tells you otherwise . this medicine should not be used in combination with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important that you continue to take januvia as long as it is of benefit to you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ): rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide [ e172 ]). what janu
xultophy helps to control blood glucose in patients with type 2 diabetes mellitus . diabetes is when your body does not make enough insulin , or the insulin that your body produces does not work as well as it should . this leads to an increase in blood sugar . insulin degludec is a long - acting basal insulin that helps your body to increase its blood sugar levels . liraglutide is a type of glp - 1 medicine that works by helping your body make better use of insulin during meals . xultophy is used in combination with oral medicines for diabetes xintophy is also used with oral
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor will tell you how long you should continue to take this medicine . warnings and precautions 39 if you have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition that occurs when your blood sugar levels are too high ). talk to your doctor or pharmacist before you start taking x
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not use more than the recommended dose , even if you feel better . use in elderly people ( blind or elderly ) if you have poor eyesight , your doctor may need to adjust your blood sugar level . how much xultophy to use the usual dose is 41 mg once a day . your doctor will tell you how many times to use each day . you should continue to use it every day until your doctor tells you otherwise . if you need to change your dose more often , ask your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common : may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). if you are not sure what to do , talk to your doctor or pharmacist before taking xultophy . warnings and precautions talk to a doctor , pharmacist or nurse before taking this medicine : serious allergic reaction (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening : chemical and physical in - use stability has been demonstrated for 8 hours at room temperature ( up to 30 ). from a microbiological point of view , the product should be used immediately . however , if not used immediately , the storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours below 21 unless dilution has taken place
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec 3 . 6 mg / ml ( corresponding to a concentration of 300 units / ml ). - the other ingredients are insulin gludec 10 . 8 mg ( correspondingto a concentration in mmol / ml ) liragolutride , glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xulophy contains sodium "). what x
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ]- erbb1 and her2 [ erbb2 - erbb3 ]. these proteins are involved in the growth and spread of cancer cells . this medicine stops these proteins from working and stops them from multiplying and growing . this helps to stop cancer cells from growing and dividing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non - small cell lung cancer ). your doctor will give you a combination of two different strengths of g
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have kidney problems . your doctor may want to monitor you more closely . have side effects associated with lung inflammation ( interstitial lung disease ). have liver problems . have had some liver tests during treatment with this medicine . have a severe liver disease . have eye problems . suffer from severe dry eyes . have inflammation of the transparent layer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is one 40 mg tablet once a day . your doctor may increase your dose depending on how you respond to this medicine . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take the tablet at any time of the day . this medicine should be taken at least 1 hour before or at least 3 hours after food . do not chew or crush the tablet . taking this medicine if you have the impression that the effect of
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea ( very common , may affect more than 1 in 10 people ). if you have diarrhoehoea , see section 2 " warnings and precautions " for more information . severe diarrhoee with or without fluid loss has been reported very commonly ( may affect up to 1in 10 people ) in patients with low blood potassium and worsening kidney function . if you experience diarrhoeea after diarrhoeing , you should contact your doctor immediately . appropriate antidiarrhoeal treatment
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections ( see section 2 under ' important information about some of the ingredients of giotrin '). what giotraif looks like and contents of
orkambi contains two active substances called lumacaftor and ivacavor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . this mutation affects the function of a protein called cftr , which is involved in the normal functioning of the body ' s immune system . the mutation causes the body to produce too much of an abnormal cfr protein , which can be detected by your breath or by your lung function , and can cause you to gain weight .
do not take orkambi : - if you are allergic to lumacaftor , ivapaftor or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given and during treatment , if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . children and adolescents do not give this medicine to children under the age of 6 years . other medicines and or kambi tell your doctor if you have ever had the f508del mutation , or if you think any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 6 mg tablet once a day for the first 12 weeks . your doctor will tell you how many tablets to take . the recommended orkambi tablet is 6 to 11 mg twice a day . if you take more than the recommended daily dose , your doctor may tell you to take a smaller or higher dose . the dose may need to be adjusted by your doctor . how often to take your doctor , pharmacist or nurse if you have to take ork
like all medicines , this medicine can cause side effects , although not everybody gets them . the majority of the side effects seen with orkambi in combination with ivacaftor have been mild to moderate . however , some may be serious . serious side effects have been reported following the use of orkammi . these include raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease and the worsening of liver function . other side effects include uncommon ( may affect up to 1 in 100 people ) the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of
what orkambi contains - the active substance is lumacaftor . each tablet contains either : lumaconaftor ( 100 mg / 125 mg ) or one tablet containing lumacftor ( 125 mg / 150 mg ) ivacaftOR ( 125mg / 200 mg ). - the other ingredients are : o tablet core : either orkyambi 200 mg : either one tablet contains 200 mg or one film - coated tablet contains 250 mg or two tablets contain 200 mg of lumcaftor and one tablet contain 125 mg or three tablets contain 150 mg or four tablets contain 140 mg or more of the active
what lynparza is and how it works the active substance in this medicine , olaparib , is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors cause death of cancer cells by stopping the activity of an enzyme needed to repair dna . what it is used for and how the medicine works lynparanza is used to treat adult patients with ovarian cancer ( brca - mutated ovarian
you must not be given lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children less than 6 years of age . the use in children below 2 years is not recommended . if you have any further questions on the use of this product , ask your doctor or pharmacist . if any of these apply to you , tell your doctor . if your child is not sure , talk to his / her doctor
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose for adults is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg once a day depending on how you respond to the dose . the doctor will tell you how many tablets you need to take . if you take more than one tablet a day , take your dose as soon as you remember . do not take a capsule at the same time each day . how to take take the tablet with food . it is important that you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( might affect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep any lynparza capsules in the outer carton in order to protect from light . after first opening of the bottle , store in the original carton at room temperature ( up to 30 ) for a maximum period of 3 days . discard any capsules that have been accidentally frozen . the capsules should be returned to the refrigerator at the end of this 3 - day period or discarded .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white to off - white opaque , hard capsule with the company logo and " olam 50 mg " printed in black ink on the cap and plain on the body . the capsule is embossed with " n
what nyxoid is this medicine contains the active substance naloxone which is used to treat opioid overdose in adults . opioids are heroin , methadone , fentanyl , oxycodone , buprenorphine , or morphine . noxoid is used as a nasal spray during the emergency treatment of opioid overdose . opioid overdose occurs in approximately 14 % of people who are treated for overdose . the most common signs of overdose are breathing problems and severe sleepiness . if you think you may have been given an opioid overdose , tell your doctor or get emergency medical care immediately .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you have an opioid overdose . it is important to know the signs and symptoms of an overdose before you use this nasal spray . if you think you may have been given too much , contact your doctor or the nearest hospital emergency services straight away . you should not use a new nasal spray until your doctor tells you otherwise . this medicine is not
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not use more than the recommended dose . 1 . symptoms should be : shoulders , ears , breastbone , sternum or inside the ear . fingernail . 2 . clear the mouth and nose of any blockages . 3 . breathe in through the mouth or nose . 4 . breathing is the chest moving through the chest . you may hear breathing sounds and breath on the cheek . overdose may be life - threatening . response to touch or sounds , slow uneven breathing , breathing , sn
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and tell your doctor straight away : acute withdrawal symptoms have been reported in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . this is uncommon ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of ndaloxone ( as hydrochloride dihydrate ). - the other ingredients are : trisodium citrate diydrate , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack the clear , colourless to pale yellow solution is a 0 . 1 ml spray in a pre - filled nasal spray . it is supplied in a single dose container . each pack contains one or two nasal sprays . not all pack
this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries , and in the production of sperm . ovaleap is used to produce a immature egg cell after treatment with a medicine called " clomifene citrate ". it is used during assisted reproductive technology procedures ( procedures to help a woman become pregnant ) in women who are not ovulating and who have not previously received a medicine named " lutropin
do not use ovaleap : if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the part of the brain that produces hormones ), such as large ovaries or sacs of fluids from the ovaries ( ovarian cysts ), unexplained vaginal bleeding , cancer in your ovaries , womb or breasts , any condition that makes normal pregnancy impossible , such as ovarian failure in early menopause , fibroid tumours of the womb , malformed reproductive
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how many days of the cycle you need to take the medicine . the recommended dose is one 75 mg or 150 mg tablet of this medicine once daily for 7 days ( corresponding to a total of 14 days ). the usual dose is 37 . 5 mg or 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . signs of severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) type of reaction may occur after your ovalesap injection . tell your doctor immediately if you notice any of the following serious sideeffects in women lower stomach ache , nausea and vomiting . these may be the symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . after first opening , this medicine may be stored for a maximum of 3 days at room temperature ( up to 25 ). if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . after 3 days , the cartridge must be used within 28 days or
what ovaleap contains - the active substance is follitropin alfa . each ml of solution for injection ( injection ) contains either : one 300 micrograms / 0 . 5 ml dose ( equivalent to 300 microlitres ) or one 22 microgramS / ml dose [ equivalent to 1 . 5 microlitre ] of follitonropin alpha . each cartridge contains one 600 microgram / 1 . 25 ml dose . - the other ingredients are sodium dihydrogen phosphate dihydrate , sodium hydroxide , mannitol , methionine , polysorbate 20 , benzyl alcohol ,
voriconazole accord is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat : invasive aspergillosis ( a type of fungal infection caused by Aspergillus sp ) and candidaemia ( an advanced form of serious invasive candida sp ). in non - neutropenic patients ( patients with abnormally low white blood cells count ) to treat candida spots infections when the fungus is resistant to fluconazole ( another antivungal medication ), to treat serious fungal
do not take voriconazole accord : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below have not been studied in this age group . warnings and precautions talk to your doctor or pharmacist before taking vORiconazol accord treatment 46 - terfenadine ( for allergy ) astemizole ( used to treat allergy ) cisapride ( used for stomach problems ) pimozide ( for mental illness ) quinidine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be given as 40 mg twice a day for 24 hours . the dose will then be increased to 400 mg three times a day ( every 12 hours ) for 12 hours and then to 200 mg two days a week ( every 24 hours ). your doctor may increase the dose to 100 mg once daily depending on how you respond to treatment . the maximum
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual
what voriconazole accord contains - the active substance is vorinazole . each film - coated tablet contains 50 mg of voronazole ( as besilate ). - the other ingredients ( excipients ) are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), lactosemonohydrate and triacetin . the film - coating contains sunset yellow fcf ( e110 ) colour . what vor
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older who have been exposed to ebola virus and who have completed a 2 - dose course of vaccinations . the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine works by stopping the spread of the whole ebolairus in your body . it does not give you ebola fever disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of the following vaccinations : -
follow carefully all instructions given to you by your doctor , pharmacist or nurse . you should not receive the vaccine : if you have ever had a severe allergic reaction to any of the ingredients in the vaccine ( listed in section 6 . if you know that you have a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine may not fully protect all persons who are vaccinated . warnings and precautions talk to your doctor or nurse before receiving mvabea if you or your child : have ever suffered from asevere allergic reaction after any other vaccine injection . have ever fainted following an injection . bleeding or bruise easily
your doctor or nurse will give you the vaccine by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the first dose of vaccination with zabdeno vaccine will be given 8 weeks later than with mvabea vaccine . the second vaccine should be given at least 8 weeks after the first . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . children and adolescents the recommended dose of vaccine is as follows : primary vaccination first vaccination : one dose ( 0 . 5 ml ) of zab deno red
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common : may affect up to 1 in every 10 people : feeling sick ( vomiting ) itching where the vaccine is given uncommon : may effect up to1 in every 100 people : redness , skin hardness where thejection is given generalised itching . the most common side effects are : common : affects up to one in every 1 ,
what mvabea contains the active substance is zaire ebolavirus 29 produced by recombinant dna technology in tai forest ebolavirus nucleoprotein marburg at a concentration of 0 . 7 to 108 μg / ml . the other ingredients are : chicken embryo embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ) as well as trace amounts of the following ingredients : a suspension . a single - dose glass vial with a rubber stopper and yellow cap .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat can also be used if you have a raised calcium level in your blood due to a tumour that has been lost from your bones . this helps to stop the bones from getting weaker .
do not take bondronat : if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have ever had a side effect called osteonecrosis of the jaw ( onj ), which can lead to bone damage in the jaw . your doctor may need to adjust your dose or stop bondronatin if you suffer from cancer or related conditions . onj can be life - threatening and can be fatal after stopping treatment . on
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for cancer is one infusion into your vein once a week . your doctor will carry out regular blood tests while you are using bondronat . the dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 weeks ( 3 - 4 weeks ) for an infusion in your vein . this may take up to 15 minutes . in case of a raised calcium level in your blood , your doctor may reduce your dose by 1 to 2
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect less than 1 in 10 , 000 persons ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . this product should be disposed of in accordance with local requirements .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion ( equivalent to 2 mg ibondronic acid ). - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water and water for injections . what bondsronat looks like and contents of the pack the concentrate is a clear , colourless to pale yellow solution supplied in a glass vial with a bromobutyl rubber stopper . each carton contains one vial .
what zeposia is and what it is used for it is a medicine that contains medicines that stimulate the number of white blood cells ( lymphocytes ) in the body to increase . what is zeposeia used for zepoesia is used to treat relapsing remitting multiple sclerosis ( rrms ) in adults with active disease . how does it work ? multiple sclerosis is a disease in which the immune system ( the body ' s defences ) attacks the nerves in the brain and spinal cord , causing symptoms such as numbness , difficulty in walking and problems with vision and balance . relapses remitting ms
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severely weakened immune system ( e . g . a heart attack , angina , stroke , mini - stroke or transient ischemic attack [ tia ]) if you suffer from severe heart failure within the last 6 months if you develop irregular or abnormal heartbeats ( arrhythmia ) if your heart is not working properly ( see section " warnings and precautions "). if any of these apply to you , tell your doctor before treatment is started . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need based on your heart rate and will prescribe you a ' treatment initiation pack ' that is suitable for you . the initiation pack is available for adults and children aged 4 years and older . the recommended dose is 0 . 23 mg ozanimod once a day . this is taken as 1 capsule in the morning and 4 capsules in the evening . depending on how you respond to treatment , your doctor may increase your dose to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( increase in blood pressure ) uncommon : may affect up to 1 in 100 people : allergic reaction . the signs may include a rash . other possible side effects are listed below . very common : side effects may occur with zeposia : common : may effect less than 1in 10 people : infections of the nose or nostrils , nasal cavity , mouth ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any damage to the pack , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg ( 0 . 22 mmol ) ozanimog ( as hydrochloride ). each capsule of zeposeia 0 . 46 mg contains either 0 . 48 mg or 0 . 47 mmol ( 23 . 5 mmol ). - the other ingredients are : capsule contents : microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : 0 . 03 mg : gelatin , titanium dioxide ( e171 ), yellow iron oxide ( e172 ),
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umeleclidinnium bromeide and / or vilterol belong to a class of medicines known as bronchodilators . what temybelipta is used for and how it is used in people with copd the muscles around the airways tighten , making breathing difficult . this medicine works by relaxing these muscles in
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you think any of these apply to you , tell your doctor or pharmacist before being given temybric ellipta . asthma : if you have asthma , heart problems , high blood pressure , liver problems , tuberculosis ( tb ) of the lung , or any long standing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used for 24 hours . try to use temybric ellipta at the same time each day . swallow the capsules whole with a glass of water . do not chew , crush or split the capsules . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . it may take longer than usual for you to feel better . if your symptoms do not improve after
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) ( copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection ( candidiasis )
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic as a solution for injection ( equivalent to 65 microlitres of umeleptiniumbromide ) and 55 micrometrombocarbonate ( as the active substance ). - the other ingredients are ( excipients ) are : capsule content : maize starch , lactose monohydrate ( see section 2 under ' temybaellipta contains lactose '), magnesium
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used in adults to treat an infection of the lungs called ' pneumonia '. how it works zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo : if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . tell your doctor if you : have kidney problems . have ever had seizures ( convulsions ). have ever suffered from any non - severe allergic reaction with other antibiotics such as
the recommended dose of zinforo is 600 mg once a day . your doctor may increase your dose to 600 mg every 8 weeks , depending on how you respond to treatment . some infections may be serious and need immediate medical attention . the recommended dose is 8 to 12 doses given by a drip into a vein over a period of 5 to 60 minutes . if you are given more than 120 doses , your doctor will give you an increased dose . the duration of treatment is 5 to 14 days . you will usually be treated for skin infections for 5 to 7 days . pneumonia if you have kidney problems if you suffer from kidney problems
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zinforo and see a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea or stool that contains blood or mucus . your doctor may decide to reduce the dose or stop treatment completely or stop the use of this medicine completely . medicines to slow bowel movement may affect more than 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is ceftaroline fosamil . - the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain : pregabalin pumpfizer is used for the treatment of long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neurological pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles , and may be life - threatening . in addition ,
do not take pregabalin pfizer : - if you are allergic to pregaabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . some patients who have taken a large dose ( more than one tablet in one day ), have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience a manifestation of these reactions , you should contact your doctor immediately . the following have been reported in patients
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregabialin pumpfizer . you should swallow the capsule whole with a glass of water . you can take your capsule with or without food , either in the morning or in the evening . if you weigh 59 kg or more , you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance , fall , dry mouth , const
what pregabalin pfizer contains - the active substance is pregaabalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg , or 300 mg of pregibalin . - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica ( e551 ). - the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ),
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical that is involved in movement and is important for the brain to function normally . in parkinson ' s disease , changes in the amount of dopamine produced occur in many parts of the body . these changes can lead to sudden swings in the ability to move and difficulties moving . xadago can be used alone or in combination with the medicine levodopa , or with other medicines used to treat the condition .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine ( which are all used in treatment for parkinson ' s disease and depression ) pethidine ( a strong pain killer ) which is used in children and adolescents up to 7 years of age .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . xadago is available in two strengths : 50 mg and 100 mg . the recommended dose is one tablet taken by mouth once a day . your doctor will prescribe the strength that is right for you . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take the tablet at about the same time each day . you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet as this may affect its absorption . if necessary
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis : very high blood pressure may lead to collapse ( neuroleptic malignant syndrome ). signs may include confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness and hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa and other medicines used to treat the condition : common ( may affect up to 1 in 10 people ): insomnia
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet is made up of three different components : - safrinamide , methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ) and iron oxide red ( e172 ). what xADago looks like and contents of the pack xadagon 50 mg film coated tablets are white to off - white , bicon
zytiga is a medicine that contains abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in the blood . this is important because prostate cancer cannot be cured by hormone therapy . a treatment that lowers testosterone ( androgen deprivation therapy ) is another medicine that you take with prednisone . prednisolone is used in patients with high blood pressure because it reduces the amount of water in your body , and so reduces the risk of fluid retention in your blood .
do not take zytiga : if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking ztiga . if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . tell your doctor before taking this medicine if you : have liver problems such as high blood pressure , heart failure , low blood potassium . have heart rhythm problems or other heart or blood vessel problems . have an irregular or rapid heart rate , shortness
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 1 , 000 mg twice a day . you should continue taking this medicine until your doctor tells you otherwise . this medicine is for oral use . swallow the tablet whole with a glass of water . do not chew or crush the tablet . take the tablet by mouth . if you take more zytiga than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . if possible , show the doctor your pack of tablets .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may want to increase your dose of potassium . other possible side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( signs of low blood potassium or liver function test ). - high blood pressure . - urinary tract infection . - diarrhoea .
what zytiga contains - the active substance is abiraterone acetate . each tablet contains nominally 250 mg abdominalateroneacetate . - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " important information about some of the ingredients in this medicine " for further information on the contents of the pack - zytigo tablets are white to off - white , round , 9 . 5 mm in
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . the active ingredient in hefiya , addalimumab , is a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). monoconlonal antibodies are proteins that recognise and attach to specific targets in body cells . the target of adal
do not take hefiya : - if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your child ' s doctor , pharmacist or nurse before taking this medicine - if the child has a severe infection , such as tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems or moderate or severe heart failure . your child may be at higher risk of developing a serious heart condition . allergic reaction if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor will tell you how many tablets to take and how long you should continue to take them . the dose may be increased or decreased depending on your response to the medicine . for polyarticular juvenile idiopathic arthritis age and body weight how much to take adults and children from 2 years of age weighing 30 kg or more 40 mg tablets as prescribed by your doctor . for children and adolescents from 2 to 10 years old weighing less than
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months after the last hefiya injection . tell your doctor straight away if you notice any of the following signs of allergic reaction : heart failure , severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath or swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a single period of up to 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe must be used within 14 days or disposed of . do
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adlimumab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol ( e421 ), polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections ( see section 2 ). what hefaya looks like and contents of the pack hafiya 20 mg solution for injection ( injection ) is a clear to slightly opalescent , colourless to slightly yellowish solution .
the active substance in ritemvia is rituximab , a type of protein called a " monoclonal antibody ". it sticks to a target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the target protein " b- lymphocyte , ritukimab sticks to the surface of this cell and stops it from growing . how rithvia is used for the treatment of patients with : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue ( part of the immune system ) that affects an important type
do not take ritemvia : - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a weak immune system - have severe heart failure or severe uncontrolled heart disease - have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section " other medicines and
how much ritemvia is given your doctor will work out the dose of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may lower your dose . how is rithvia given rithromycin is given as a drip ( intravenous infusion ) into a vein . medicines given before each rithmvia administration you will be given ritvia in combination with other medicines ( pre - medication ) to reduce the risk of side effects . the duration of your treatment will depend on how well
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of powder for concentrate contains 10 mg / ml of solution for injection . - the other ingredients are : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritvia looks like and contents of the pack ritem via is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth and spread of cancer cells . capecitabrine teva is a type of medicine known as a cytokostatic medicine . it is an active anti - cancer medicine that works by stopping the growth of certain types of cancer in your body ( for example , colon , rectal , gastric , or breast cancers ). furthermore , capecitabe teva can be used alone or in combination with other medicines for the treatment of colon cancer after complete removal of the tumour by surgery ( see section 2 ). capecit
do not take capecitabine teva - if you are allergic to cape citabine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : - have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) - are pregnant - have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the recommended dose of cape citabine teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body square area taken once daily . this is equivalent to a daily dose of body weight of 64 kg and height of 1 . 64 m² taken once
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you get any of these symptoms : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movements . if any diarrhoehoea occurs at night , vomiting , vomit , nausea and you may lose your appetite . stomatitis : pain , redness , swelling or sores in your mouth and / or throat . hand - and - foot skin - reaction : pain and swelling ( including redness and tingling of
what capecitabine teva contains - the active substance is capecabine . each film - coated tablet contains 150 milligrams ( mg ). - the other ingredients are tablet core ( tablet core ) hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , talc ( e553b ). tablet coating ( tablet coating : hypromellaose , titanium dioxide ( e171 ), yellow iron oxide ( e172 ) and red iron oxide [ e172 ). what cape citabrine teva looks like and contents of the pack capecitabe teva 150 mg film
silodosin recordati belongs to a group of medicines known as alpha1a - adrenoreceptor blockers . silodosic recordati works by blocking signals to the prostate , bladder and urethra , causing smooth muscle in these tissues to relax . this will help to control your symptoms and reduce your need for sexual activity . your doctor has prescribed silosinrecordati for you to help alleviate the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to siliodosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using silosinrecordati . before eye surgery if you experience cloudiness of the lens during cataract surgery , your eye will be examined 26 carefully before and during treatment with siloosin Recordati . this is because medicine may cause a loss of muscle tone in the iris ( the coloured part of the eye ) during a surgery . your doctor will take appropriate precautions , including
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is 8 mg once a day . patients with kidney problems if you have moderate kidney problems , your doctor may prescribe a lower dose . your doctor will prescribe the dose that is right for you . swallow the capsule whole with a glass of water . do not chew , crush or split the capsule . for patients with this type of kidney problems the dose may need to be adjusted by your doctor . if you take more than you should if you
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect of silodosin recordati is dizziness . if you experience dizziness and / or occasionally fainting , you may feel weak or dizzy . if the symptoms of dizziness are severe , you should contact your doctor immediately . faints have been reported in association with the use of the product in children and adolescents . your doctor may decide to temporarily or permanently stop silod
what silodosin recordati contains - the active substance is silosin . each capsule contains 8 mg of silodosein . - the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate ( e470b ), sodium laurilsulfate , gelatin , titanium dioxide ( e171 ) ( see end of section 2 ). capsule shell : white , opaque , hard gelatin capsules , with a diameter of 4 mm , with silodusin ( e464 ), mannol ( e422 ), magnesium starchate ( i470b ) ( e570b ) and sodium l
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . ' essential ' means that the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not take this medicine and talk to your doctor , pharmacist or nurse before taking it . if you ( or your child ) are more than 3 months pregnant , think you may be pregnant , or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . ( see section " pregnancy and breast - feeding "). if you have severe liver problems such as cholestasis or biliary obstruction
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . it is important that you take kinzalmono every day until your doctor tells you otherwise . the tablets should be swallowed whole with some water or other non - alcoholic drink . you should not take more tablets than your doctor recommends . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other possible side effects of kinzalmono common side effects ( affects more than 1 user in 10 ): low blood pressure ( hypotension )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect from moisture . remove your kinzalmono tablet from the blister only directly prior to intake .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate ( e470b ) and water for injections ( see section 2 ). what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round , biconvex , convex and embossed with " gsi " on one side and plain on the other
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). the active substance is lonoctocog alfa . afstylfa is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor iii is involved in blood clotting and is necessary for blood to clot . patients with an increased tendency to bleed have been shown to have been more likely to have this problem when they were growing up . factor iii can also play an important role in helping your body to clot
do not use afstyla - if you have ever had an allergic reaction to any of the ingredients in this medicine ( listed in section 6 ). if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should check with your doctor or pharmacist if you think any of these apply to you . the dose and duration of administration should be recorded on the patient alert card and in your treatment diary . do not stop treatment unless your doctor tells you to . if you develop allergic ( hypersensitivity ) reactions while you are being treated with afst
your treatment will be overseen by a doctor experienced in the care of patients with blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla you receive will depend on the duration of treatment , the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) must be dissolved before use in order to avoid aseptic conditions . if you have not been trained in this type of preparation , you may not be able to use
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding caused by factor viii medicines ). inhibitor antibodies ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) patients who have received previous treatment with factor v iii ( more than 150 days of treatment ) and who were treated with more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 hours at 2 to 3 , unless dilution has taken place in controlled and validated
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu / 2 . 5 ml of solution for injection . after reconstitution with 2 . 25 ml of water for injections the solution contains 200 iu of loroctocag alfa ( corresponding to 1000 iu in international units ). each pack contains one vial of powder for injections , one pre - filled syringe and one syringe with solvent for injections . each multipack contains either 100 iu or 500 iu ( international units ) of lanoctocg alfa , corresponding to
what praxbind is and what it is used for the active substance in this medicine , idarucizumab , is a recombal agent . it dissociates from dabigatran ( pradaxa ), which is a blood thinner medicine used to prevent blood clot formation . what itis used for ? what is used ? when used in adults , it reduces the amount of medicine that can be absorbed by the body and so reduces the need for blood clot formation . how is it used ? your doctor has prescribed a medicine that helps you to rapidly trap dabigatheran . what is the use of
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfi ). if this applies to you , do not take the substance sorbitol . warnings and precautions talk to your doctor or pharmacist before taking this medicine . serious adverse reactions have been reported with the use of the active substance dabigatran . other medicines that may increase the risk of blood clots dabigATran has been shown to lower the chances of blood forming . medicines to prevent blood cl
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg film - coated tablet of 2 . 5 mg dabigatran per day to be taken orally with or without food . you should swallow the tablet whole with a drink of water . this medicine can be used for up to 5 days . you will be given this medicine by infusion into a vein ( intravenously ). if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . your treatment will be overseen by a doctor experienced
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ) and polysorbate 20 . - water for injections . what Praxbind looks like and contents of the pack the clear , colourless to slightly opalescent , clear to slightly yellow solution is supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme ( gli ) - in children and adolescents - in combination with radiotherapy ( concomitant phase of treatment ) and / or monotherapy phase oftreatment ( phase 3 ). - in adult patients with malignant glioma , such as gliOBlastoma multipurpose or anaplastic astrocytoma ( mast ). temomedic is used
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help your body with fighting infection when proper blood clotting is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour and have had chemotherapy treatment in the past . your doctor may prescribe other medicines ( anti - emetics ) to help with this . the recommended dose is one tablet once a day . you should swallow the tablet whole with a glass of water . you must not crush , chew , or break the tablet before swallowing . if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( fits or convulsions ), fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this may result in increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening , the capsules should be used within 30 days . if you notice any change in the appearance of the capsules , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains ∑ the active substance is temozolomide . ∑ each capsule of temomedic 5 mg contains 5 milligrams of temozolsomide ∑ one capsule each day ( for children and adolescents ) ∑ if you are not sure , talk to your doctor , pharmacist or nurse before you start to take this medicine ∑ your doctor will tell you how many capsules to take , and how long you need to take them ∑ every other day , until your doctor tells you otherwise ∑ ∑ when you have taken the first dose ∑ after the second dose �
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis will only help you to obtain a hard erect penis if you have agreed with your partner that it would be best for you to engage in sexual activity with someone who is willing to take the risk for your own well - being , even if he or she has agreed with you that the benefits of having a hard erection are outweighed by the risks of not being able to achieve a sexual climax . the active substance tadalafil belongs to a
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) if you have a history of taking organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines : if you know that you may be at increased risk of nitrate , tell your doctor straight away if you : have serious heart disease have recently had a heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual starting dose is between 5 mg and 2 . 5 mg per day . your doctor will tell you how many tablets to take . if you have the impression that the effect is too strong or too weak , talk to your doctor . how long you should continue taking cialsis your doctor may tell you to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions including rashes ( frequency not known ) and chest pain have been reported in patients taking nitrates . the frequency is not known ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . stop taking cialis and get an erection straight away ( see section 4 , " warnings and precautions "). contact your doctor immediately if you experience sudden loss of vision . this is not of the frequency listed in this leaflet . other side effects
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of dlabs ( as mesilate ). - the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : cellulose ( e460i ) ( e464 ), lactosemonohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow (
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . enyglID helps control the level of sugar in the blood after meals , and helps prevent diabetes . treatment is usually started by diet and exercise and weight reduction . your doctor will work out how many tablets you need to take each day to control yourblood sugar
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels ). have liver problems . have moderate liver 28 disease . see section 2 . do not take the medicine if any of these apply to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . try to take your daily dose at about the same time each day . this will help you remember to take it . however , if it is almost time for your next dose , skip the dose you missed and go back to your regular schedule . do not take a double dose to make up for a forgotten dose . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequently reported side effect of enyglid is hypoglycasemia ( very common : may affect more than 1 in 10 people ) which may be severe . in very rare cases , the following reactions have also been reported : very rare ( may affect up to one in 10 , 000 people ) but very serious cases have been reported . signs and symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects may include : very common ( may
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet only in 2 mg tablets only in 3 mg tablets . - white , round and biconvex with bevelled edges . -
the active substance of azacitidine mylan is called azapitidine . this active substance is an anti - cancer agent . what it is used for the active substance in this medicinal product is called rifampicin . what azaccitidine myl is used in this medicine is for use in adults only . it is given to you by your doctor as a stem cell transplantation . in adults with higher - risk myelodysplastic syndromes ( mds ). in adult patients with chronic myelomonocytic leukaemia ( cmml ). in children with acute myeloid
do not take azacitidine mylan - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have : - decreased counts of platelets , red or white blood cells - kidney disease - liver disease - a heart condition ( e . g . heart attack ) - lung disease your doctor will ask you to have blood test periodically during treatment . your doctor may decide to reduce the dose or stop treatment
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet once a day . your doctor will tell you how many tablets of this medicine you need to take , based on your height and weight . you will usually be given one tablet once daily during the first 3 weeks of this " treatment cycle " ( cycle 4 and 6 ). this medicine should be injected under the skin ( subcutaneously ) by a doctor or nurse . it can be given on any skin surface ( such as the thigh , tummy or upper arm ). if you have any
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these could be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these may be symptoms or signs of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton after exp . this medicine does not require any special temperature storage conditions . after reconstitution , chemical and physical in - use stability has been demonstrated for 1 hour at 25ºc . when reconstituted as directed by your doctor , your doctor or pharmacist , you will need to use the azaccitidine Mylan suspension in water for injections . the suspension will be stored in a refrigerator ( 2 - 8 ) for up
what azacitidine mylan contains - the active substance is azapitidine . one vial of powder contains 100 milligrams ( mg ) of azacinidine . after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg / ml ( 0 . 5 %) azaccitidine . - the other ingredient is mannitol ( e421 ). see section 4 for further information on the use of this product in children and adolescents . what azacididine Mylan looks like and contents of the pack azacitonidine myl is a white
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol in one drop . travostrost is a prostaglandin analogue , which helps to lower pressure in the eye when it is used in adult patients , and is a beta blocker that reduces the amount of fluid within the eye . lowering pressure within theeye is important for lowering the pressure of the eye , which can lead to an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( wheeziness , difficulty in breathing , long - standing cough , breathing problems ), severe hay fever ( a slow heartbeat ), heart failure ( a disorder of heart rhythm ), or if your eye becomes cloudy . warnings and precautions talk to your doctor or pharmacist before taking duot
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes twice a day . do not use duotrav in both eyes unless your doctor tells you to . how to use wash your hands before using duotrave . the recommended amount of eye drops is 1 drop in each affected eye , 3 times a day , for 4 weeks . a bottle is provided with each bottle , containing 1 drop . hold the bottle with both hands . remove the bottle from the bottle , pointing down with
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the effects above , stop using duotrav and talk to your doctor straight away . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . this is a common side effect that may affect up to 1 in every 10 people . the eye surface inflammation or surface damage may cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging . uncommon side effects these may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . after first opening , use within 4 weeks to prevent infections .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg of tritonavir . - the other ingredients are propylene glycol , polyoxyethylene hydrogenated castor oil ( 40 mg / ml ), boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water ( e . g . sodium hydrochloride and / or water for injections ) and hydrochlorIC acid . - acidity levels may be raised ( ph levels may increase ) by lowering the amount of acid in the liquid ( a clear , colourless
nplate ' s active ingredient is romiplostim . it is a protein that is used to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in protecting your blood from blood clots . very lowplatelet counts can lead to bruising and serious bleeding . nplate is used in adults , adolescents and children aged 1 year and above who have had their spleen removed and who have chronic itp previously treated with
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking nplate : if you have a low blood platelet count ( thrombocytopenia ) your doctor may decide to reduce your dose of nplate , or temporarily reduce yourplatelet count , to reduce the risk of blood clots . if you suffer from a condition that reduces blood clotting , such as liver problems , your doctor will
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 1 to 17 years ) the recommended dose of nplate is one tablet once a day . nplate should be injected under the skin ( subcutaneous ) at least 1 hour before or one hour after taking nplate . your doctor will check your platelet counts regularly . you will have regular blood samples taken to measure the number of your platelets . the dose will depend on your body weight . if you use more nplate than you should if you think you may have injected
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection ( common ) and other respiratory tract infections ( common ). common : may affect up to 1 in every 10 people : bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness or the skin ( flushing ), blood clot in a lung artery ( pulmonary emb
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening , use within 30 days . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . each vial of nplate 125 mg solution for injection contains 230 mg ( 25 milligrams ) of romplostim ( as 125 mg ). each single - dose glass vial contains 125 mg ( 26 . 5 milligram ) of the other active substance . each single dose contains 375 mg ( 28 . 3 milliggrams) of romoplostim , as 250 mg ( 24 . 3 micrograms ). each individual dose contains 500 mg ( 23 . 5 million ) of both active substances . - the other ingredients are : nplate
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . using this medicine will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have kidney problems - have an eye problem called narrow - angle glaucoma - have difficulty passing urine . your doctor may decide to reduce the dose or stop treatment if you have any of these conditions . if you think that you may have been given too much of the medicine , tell your doctor or pharmacist immediately . - have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation once a day . you should inhale this medicine every 24 hours at about the same time each day . your doctor will tell you how many capsules to use and how long you should continue to use it . the maximum recommended dose is 75 inhalations per day . do not use more than this medicine twice a day , as this medicine may affect your ability to breathe . this medicine comes in blisters
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycoprroniumbromide , equivalent to 50 micrometres ( mpa ). each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 44 microg glycopyronium . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate ( e470b ) ( see section 2 ). what you need to know before you inhale the full contents of the pack tovanor bree
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , seeing or sensing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the signs of bipolar
do not take adasuve : - if you are allergic to loxapine or any of the other ingredients of adasve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking adsasuve if you : - have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or shortness of breath 25 - have neuroleptic malignant syndrome ( nms ), a group of symptoms that have been reported in patients taking antipsychotic medicines . these symptoms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( for 2 mg and 4 . 5 mg ). if your condition worsens , your doctor may prescribe a lower dose . adasuve is for oral use . it should be taken by mouth . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . if you use more adsasuve than you should contact your doctor immediately if you experience any of the following symptoms : extreme tiredness , sleep
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking adasuve and see a doctor straight away if you notice any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include :
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . store the blister inside the pouch to protect it from light and avoid physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine and delivers 4 . 5 mg / ml ( 23 mg / 0 . 25 mg ) loxagine . what adasuves looks like and contents of the pack adasve 4 .5 mg is a white to off - white plastic inhaler , containing a covering to protect the inhaler from moisture . each inhaler is packed in a sealed foil pouch and is available in packs containing 1 or 5 inhalers . not all pack sizes may be marketed .
what azacitidine betapharm is and how it works azacitonidinebetapharm acts as an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what it is used for the active substance in this medicine is called azapitidine . what azaccitidine betabarm is used in adult patients azacuitidine bequeathed to you by a stem cell transplantation is used to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute my
do not take azacitidine betapharm - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you have decreased counts of platelets , red or white blood cells . your doctor may ask you to have blood test before you start treatment . blood tests before you begin treatment , your doctor will check whether you have enough blood cells and to check that your liver and kidneys are working properly . children
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many days you need to take this medicine . the dose will depend on your height and weight . you will usually be given one tablet once a week for the first 3 weeks of this " treatment cycle " ( cycle 4 and 6 ). this medicine is given under the skin ( subcutaneously ) or on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this medicine , ask your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( symptoms of kidney failure ). a fever may be a sign of an infection with low levels of white blood cells . chest pain or short
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . after reconstitution , the medicine must be used immediately . the suspension must be administered within 45 minutes of preparation . the reconstituted solution for injection must be clear , colourless and free from visible particles . if the solution is not clear and free of visible particles
what azacitidine betapharm contains - the active substance is azapitidine . each vial contains 100 mg of azaitidine ( as besilate ). after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml ( 0 . 5 %) azaccitidine . - the other ingredient is mannitol ( e421 ). see section " important information about some of the ingredients of azacitonidinebetapharm " for further information . what it looks like and contents of the pack azacituidine betabarm is a white to
the active substance in cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . if you do not respond normally to the medicine , you may not be able to take it . your doctor will test your affected organs to make sure that it is working properly . this medicine will be prescribed to you by a doctor who is experienced in the treatment of patients with this condition .
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called " moderate cyp2d6 inhibitors " ( e . g . quinidine , terbinafine ) 31 - moderatecyp3a inhibitors such as erythromycin or itraconazole . these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor , pharmacist or nurse before you are given Cerdelga : if you are being treated with medicines that make you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet twice a day with or without food . your doctor will tell you how many tablets to take . the amount of metaboliser to take depends on how much you are taking . the recommended daily dose is : one tablet ( 84 mg ) once a day . if you take more cerdelga than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . take the tablet pack with you so that you can easily describe
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations ( throat irritation ) heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin h
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the sleeve after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 under ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cerDelga looks like and contents of
the active substance in zoledronic acid hospira is zoledor acid , which belongs to a group of substances called bisphosphonates . zoledron acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( a type of cancer that affects the primary site of bone ). it reduces the amount of calcium in the blood in patients where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given this medicine if any of the above apply to you . if you are not sure , talk to your doctor or pharmacist before you are given the medicine . warnings and precautions you should tell your doctor if you have or have ever had : - a kidney problem . - pain , swelling or numbness of the jaw , or a feeling of heaviness in the jaw or loosening
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . ' iv ' administration is recommended in order to prevent dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg once a day . if you have a kidney problem , your doctor may lower your dose . if your kidney problem is not well controlled with other treatments , your dose may be reduced . how often is given ? if you are being treated for the prevention of bone complications ( e . g . from bone metastases ), your doctor will
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness or loosening of a tooth . these could be signs of bone damage in the jaw (
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zolingronic acid . one vial contains 4 mg zoledron acid ( as monohydrate ). - the other ingredients are mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is supplied as a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains a single vial of concentrate . not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) at the start of cancer treatment chemotherapy . chemotherapy destroys nerve cells in the brain . this can cause people to have fits , nausea and vomiting . when you feel sick , or are sick more than usual , you may be given varuby to stimulate the growth of these nerve cells . this will help to prevent nausea or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ) used to treat depression and difficulty sleeping ( see section 2 " warnings and precautions "). if this applies to you , tell your doctor before taking this medicine 27 if you have severe liver or kidney problems . if you currently take certain medicines ( e . g . rifampicin , used for tuberculosis or other infections ), such as carbamazepine ( used for epilepsy and nerve
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . take the tablet at least 2 hours before or at the start of your chemotherapy cycle . your doctor will tell you how many days of chemotherapy you need to take . if you have sickness or if you feel sickness after taking this medicine , your doctor may tell you to take a smaller dose . do not stop taking var
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . you should contact your doctor immediately and receive appropriate treatment . other side effects may include : very common : may affect more than 1 in 10 people : headache ; constipation ; feeling tired uncommon : may affects up to
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapitant . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubsy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . tablet coat : blue 100 mg film - coated tablet
what enerzair breezhaler is the active substance in this medicine is indacaterol - glycopyrronium - mometasone furoate indacterol and glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the lungs and helps to keep open the smaller airways . what it is used for and why it has been prescribed for you by your doctor , pharmacist or nurse ? cortic
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems ( such as diabetes , high blood sugar , seizures ) - have severe kidney problems , severe liver problems , low level of potassium in your blood - have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale the medicine at the same time each day . it is important that you use enerzair breezhaler every day until your doctor tells you otherwise . if your asthma does not improve or your symptoms get worse , your doctor may prescribe a different dose . how much to use the active substance in this medicine is called an inhaler and capsules . the medicine is contained in a separate sachet . the inhaler contains the medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other possible side effects are listed below . very common side effects ( likely to affect up to 1 in10 people ): sore throat , runny nose , sudden difficulty breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . once opened , the capsules should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc to 8ºc , unless dilution has taken place
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate ( asacetate ), equivalent to 63 microlitres of glycopreyroniumbromide ( equivalent to 50 microlitre of the two active substances ), and 160 microgigrams of the three active substances ( respectively ). each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains an additional dose of 114 microgram
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombo - occlusion ) which can lead to a dangerous process called atherothrombosis ( a condition that can lead , for example , stroke , heart attack , or
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to the active substance , or any of the other ingredients in this leaflet ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given clopridogrel agrolemais if : - you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain - you suffer from severe liver disease . if you think any of these apply to you , or if you have any further questions on the use of
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual starting dose is one 75 mg tablet taken orally with or without food . your doctor will tell you how many tablets of clopridogrel agrogrel stand up to take each day . if you take more than the recommended daily dose , contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . take your tablet straightaway ( see section 2 ). if you forget to take a tablet of
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) very rare : very rare ( affecting less than1 users in 10 , 000 ). not known ( frequency cannot be estimated from the available data ). if you experience any of the following : contact your doctor immediately : - fever , signs of infection or extreme tired
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . any unused tablet should be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil ( type a ) hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmágmbh looks like and contents of the pack
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are already taking medicines called ' antiretroviral medicines '. the active substances in delstrigo are doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which is also a nnucleoside analogue reverse transcriptase inhibitor . in combination with nrti , tenofovir disoproxil , also known as ' nnritase inhibitor ' ( nri ), is used for the treatment of hiv
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take the following medicines : carbamazepine or oxcarbazepine , phenobarbital and phenytoin ( medicines to prevent seizure ) rifampicin or rifapentine ( medicines used to treat tuberculosis ) st . john ' s wort ( hypericum perforatum , a herbal remedy used for depression and anxiety ) products containing mitotane ( a
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet should not be used to treat hiv infection . your doctor will tell you how many tablets to take and how long you should continue to take them . this will help you to remember to take it . the dose may need to be adjusted by your doctor . it may take up to 1 year before you start taking certain medicines ( e . g . doravirine ). your doctor may tell you to take medicines
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking delstrigo and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( might affect up to 1 in 100 people ): nightmares , depression , anxiety , irritability ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". this medicine does not require any special storage conditions . the medicine should be kept in the bottle tightly closed in order to protect from moisture .
what delstrigo contains the active substances are 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl feumarate . a coating material containing carnauba wax e903 . the printing ink contains hyprogellose ( e464 ), iron oxide yellow ( e172 ), lact
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant in adults , adolescents and children aged 2 years and older . antidepressant medicines should not be used alone .
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ) or have recently had a heart attack . within 6 weeks of starting treatment , you may experience a temporary increase in blood pressure . this can lead to serious complications in these conditions . if any of these apply to you , tell your doctor or pharmacist before you are given this medicine . warnings and precautions talk to your doctor before taking
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray is for inhalation use only . the nasal spray device should be used within 1 hour . use in children and adolescents the recommended dose is 2 to 3 nasal spray devices per day . if you use more than one nasal spraydevice per day , use it within 4 hours . if more than 4 hours have passed since your last dose , use the next dose at the usual time . do not change the dose unless your doctor tells you to . use sprav
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to noise in the mouth area spinning sensation ( vertigo ) vomiting nausea very common : may affect up to 1 in every 10 people : feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes , ears or sense of touch are deceived or mimicked irritable panic
what spravato contains - the active substance is esketamine . - each nasal spray device contains an excess of esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections . whatspravato looks like and contents of the pack sprivato is presented as a nasal spray solution . this medicine is a clear , colourless solution that is supplied as a single - use nasal spraydevice . the following pack sizes are available : one bottle containing 1 , 2 , 3 or 6
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for the growth of melanoma . by blocking the action of these proteins , your medicine slows down or stops the progression of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before you are given this medicine . allergic reactions if allergic reactions occur while you are being treated with zelberaf , your doctor may decide to reduce the dose or stop your treatment . if you have any symptoms of an
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for up to 8 weeks . if you take more than 4 tablets a day , your doctor may reduce your dose to 4 tablets per day , depending on the severity of side effects and how you respond to your treatment . taking zelboraf if you experience vomiting , do not take the next dose until you have talked to your doctor . take your next dose at about the same time each day . if possible , take your tablet with food . z
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation have been reported very rarely in patients receiving zelbaf . radiation treatment tell your doctor immediately if you notice any of the following symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esophagitis ) if any changes in
your doctor , pharmacist or nurse knows how to store zelboraf properly . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of valsartan ). - the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating containing iron oxide ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood can flow freely . as a result , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken by adults to reduce the risk of bloodclots forming in hardened arteries , a process that can lead to at
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you have painful and / or inflammatory conditions of muscles or joints if you suffer from a medical condition ( e . g . asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ), if you currently have a risk of bleeding such as a stomach ulcer or bleeding within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of duoplavin you need to take and how long you should continue to take your medicine . the recommended dose is one tablet a day . you should take the tablet at the same time each day . do not take more than one tablet in the morning . if you take more tablets than you should if you have accidentally taken too many tablets , talk to a doctor or go to the nearest hospital emergency department immediately . you may be at increased risk of bleeding .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the unopened blister refers to the last day of that month . store below 25 . store in the original package in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . if you notice any visible sign of deterioration , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
duoplavin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel ( as acetylsalicylic acid (asa ), 75 mg of clopridogrel and hydrogen sulphate ). the other ingredients are : - tablet core : polysorbamide ( e1203 ), acetyl salicylic acids ( a ), mannitol ( e421 ), macrogol ( 6000 ), microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duoplin contains hydrogen
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines known as carbonic anhydrase inhibitors , which work by blocking the action of a substance in the body called brimonidase . this substance is a stimulant of the central nervous system called alpha - 2 adrenergic receptor agonists ( α - 2 agonists ), which help to reduce pressure within the eye . the active substance of simbrinz is used to treat the eyes in adult patients ( aged 18 years and older ) with eye conditions such as gl
do not take simbrinza : if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if you take certain antidepressants . tell your doctor if you have taken any antidepressant medicines in the past . warnings and precautions talk to your doctor or pharmacist before taking sim
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eyes or eyes . wash your hands thoroughly with soap and water ( see section 1 , " how to use " and section 2 ). remove the cap and snap collar before using the medicine . do not touch the medicine with your fingers . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a clean finger until there is a ' pocket ' between
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . contact your doctor immediately if you experience extreme tiredness or dizziness . side effects with simbrinza have been reported with other medicines containing brinzolamide and brimonidine . common side effects ( may affect up to 1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . after first opening , use within 4 weeks to prevent infections . if you use more simbrinza than you should do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of the active substance , brin zolamide ( corresponding to 2 mg / ml of the suspension ), and bimonidine tartrate equivalent to 1 . 3 mg of Brimonidine . - the other ingredients are benzalkonium chloride ( see section 2 " simbrinnza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydro
filgrastim ratiopharm is a medicine that contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in the body called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body but it has a very similar structure to the natural protein found in the cells of your own blood . granulocytes are a type of cell that makes new blood cells . more blood cells than white cells are needed to help your body
you must not be given filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should tell your doctor if you have ever had a cough , fever or difficulty breathing . these may be signs of a pulmonary disorder . the most common side effects reported with sickle cell disease 57 are left upper abdominal pain or pain at the tip of your shoulder . this may be a symptom of a spleen disorder .
how much filgrastim ratiopharm is given your doctor will tell you exactly how many tablets you need to take and how long you should continue to take it . if you are not sure , talk to your doctor or pharmacist . how much is given the amount given will depend on how you respond to the treatment . your doctor may decide to change your dose , or stop treatment completely , depending on how well you respond . the usual starting dose of filgrasteim ratiopharm treatment for patients receiving chemotherapy is 0 . 5 mg to 60 mg once a day for 30 days . your treatment will usually last
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will carry out regular blood tests before and during treatment . the number of neutrophils ( a type of white blood cells ) in your blood will be checked before treatment is started . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years because it has not been studied in this age group . other
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the outer carton and on the blister after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the blister in the original carton in order to protect from light . keep away from the freezing element . don ' t open the blister if you notice that the solution is cloudy . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrateim . filgraspim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg filgrasteim in 0. 5 ml solution . filgnastim ratiopharm 48 mg / 1ml : each vial contains 0 . 8 ml solution for injection . after dilution , each ml contains 48 mg ( 4 . 0 mg ) filgrastersim . - the other ingredients are sodium hydrox
what riluzole zentiva is and what it is used for the active substance in this medicine is called lusutamide . lusetamide is a substance that belongs to a group of substances called cytokines , which are involved in the nervous system and play an important role in controlling movement and movement . what rilsuzolezentiva has been given to you by your doctor is used to treat amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells in the muscles are damaged , leading to weakness , muscle waste , and paralysis . the destruction of nerve cells
do not take riluzole zentiva : if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have increased blood levels of some enzymes of the liver called transaminases . you are pregnant or breast - feeding . this is because you may be pregnant . your doctor may decide to delay or stop your treatment with this medicine . you suffer from any liver problems . you have yellowing of your skin or the whites of your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth at least 12 hours apart . if you take more riluzole zentiva than you should if you accidentally take too many tablets , contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible , show the doctor your pack of tablets . do not take a double dose to make up for a forgotten tablet . you should not take more tablets than your doctor tells you to . take the medicine pack
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check for this . this is important as it may increase the chance of you getting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor
what riluzole zentiva contains - the active substance is rilanuzole . - the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460i ), an hydrous colloidal silica , magnesium stearate . tablet coating : croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). not all the ingredients in this medicine may be present in the tablet coating ; however , if they are , they should remain in the bottle and keep the tablet tightly closed in order to protect from
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which the body produces increased levels of Cgrp . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older who have at least 4 migraines per month . emigality can reduce the frequency and severity of migraine headache and improve your quality of life .
do not use emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions ecgality may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see your doctor immediately if you experience such signs or serious side effects as described in section 4 . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years . this is because it has not been studied in this age group .
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 240 mg once a day . your doctor will decide how many days you need to take the first dose of emgally . you will be injected under your skin ( subcutaneous injection ). your doctor may decide to change the dose or delay your emgonality injection depending on your response to proper training . if you take more than the 240 mg recommended dose , you should contact your doctor . do not take a double dose to make up for a forgotten dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain . injection site reactions may include red skin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after dilution , the product may be stored for up to 7 days at room temperature ( up to 30 ) in the outer carton , but do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanesumab in 1 ml solution . - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what emgonality looks like and contents of the pack emgalis is presented as a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . the syringe is supplied in single - dose pens of 1 , 2 or 3 ml . not
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and clogged with blood clots . it may be given to you in combination with medicines you have received prior to a stem cell transplantation . your doctor will test for this effect . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - are taking other medicines to prevent blood clots ( tissue plasminogen activator warnings ) - are using medicine to prevent bleeding ( e . g . if you have heavy bleeding after a blood transfusion or surgery ) - have problems with blood circulation - have a constant blood pressure ( see section 1 ) - take other medicines ( medicines that prevent blood clotting ) such
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce the dose to a single dose . if you have any further questions about how to use this medicine , ask your doctor or pharmacist . children and adolescents do not give this medicine to children less than 18 years of age because there is no experience with
like all medicines , defitelio can cause side effects , although not everybody gets them . if you get any of the side effects listed below , talk to your doctor or pharmacist immediately . very common ( may affect more than 1 in 10 people ): low blood pressure . common : may affect up to 1in 10 people : bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine in the mouth bleeding from under the skin coagulopathy ( disturbance in blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon : may
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion storage should be completed within 24 hours of dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic conditions . however , do not refrigerate or freeze the reconstituted
what defitelio contains - the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defabrotide - the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections ( see section 2 " defitelsio contains sodium "), water for injection , and solvent for infusion . one vial contains 10 ml ( 0 . 5 %) of concentrate .
daklinza contains the active ingredient daclatasvir which is used to treat hepatitis c , an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by blocking two different proteins that are involved in the blocking of these proteins . daklinz does not completely cure hepatitis c infection ; it reduces the amount of the virus in your blood . your doctor will tell you how long you should continue to take this medicine . this is in addition to taking other medicines to prevent hepatitis c from getting worse . the other medicines that you will be taking are : - tablets , which contain the active substance
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is taking , by mouth , one or more of the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics to treat tuberculosis ) dexamethasone , a steroid ( antibiotic to treat allergic and inflammatory diseases ) medicines containing st . john '
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or split the tablet to avoid unpleasant taste . your doctor will tell you how many tablets to take each day . if you have to take some other medicines , your doctor may tell you to take a different dose . it is important that you continue to follow the instructions given to you by your doctor , pharmacist or nurse so that you can easily describe what you have taken . how long to take
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles if you have been given both of these medicines , you may experience decreased appetite , difficulty sleeping , irritability dizziness headache shortness of breath cough nasal congestion (
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) ( only in 51 mg tablets ). what dak
proquad is a vaccine to protect against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the diseases that cause mumps and rubella . when these are given to people , they can be more likely to develop diseases caused by these viruses . proquad can be given to adults , adolescents and children from 9 years of age . national vaccination schedules contain measles caused by live viruses , which can be different from those that are normally given to children . in measles , rub
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( for example , treatment with medications that suppress your immune system , e . g . low - dose corticosteroid therapy , asthma or replacement therapy ). if you suffer from a weakened immune system or have a disease ( including aids ), congenital or hereditary immunodeficiency ( immune competence ), active untreated tuberculosis , fever ( over 38 . 5
proquad is given as an injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections may be given into the muscle of the thigh area or into the upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under your skin , as this may increase the risk of bleeding . proquad is injected into a blood vessel ( intravenously ). proquad will be given to infants and children from 9 weeks of age and adolescents from 12 years of age . there is no experience with chickenpox or measles in this age group
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you experience signs of an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( might affect 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) the following side effects have also been reported during the use of proquad : very common ( may
what proquad contains - the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain 3 .00 mg varicella virus3 , merck strain ( 3 . 99 mg mrc ). - the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts ( mem , ne
jylamvo is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . by reducing the activity of the immune system , it is used to treat rheumatic and skin diseases such as active rheumatoid arthritis , polyarthritic forms of joints and severe juvenile idiopathic arthritis ( jia ) in adults , adolescents and children 3 years of age and older . it can be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) for the treatment of inadequate o severe or disabling psoriasis in adults who have not responded to treatment
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment or a liver impairment if you suffer from blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia , significant anaemia ) 34 if you know that you may have a weakened immune system and you have ever had a serious infection such as tuberculosis or hiv . if you develop ulcers in the stomach or intestines ( an inflammation of the mucous membrane of the mouth
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . the treatment should be initiated under the supervision of a physician experienced in the care of patients with rheumatoid arthritis , severe juvenile idiopathic arthritis and severe psoriasis . if you have severe psoriatic arthritis , your doctor may suggest that jylimvo be used as a long - term treatment . your doctor will decide on the most appropriate dose for you . use in children and adolescents the recommended dose
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching all over your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and the vial label after exp . store below 25 . store in the original package in order to protect from light and moisture . the medicine should be used immediately after dilution . in the event of accidental spillage , chemical and physical in - use stability has been demonstrated for 3 hours prior to administration . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of metotrexate ( as macrogol 400 mg ). - the other ingredients are glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate and purified water . see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydroxybenzanoate " for further information . what jy
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten . this makes breathing difficult . using this medicine helps to stop the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . your doctor has prescribed this medicine to help reduce the effects of copd on your everyday life .
do not use enurev breezhaler : if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from kidney problems . if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if any of these apply to you , tell your doctor before starting treatment . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after you have been given enure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine is for inhalation use only . use within 24 hours of your last dose . your doctor will tell you how many capsules to use and how long you should continue to use . do not exceed 75 days without using this medicine . how to inhale this medicine this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the capsules should be swallowed whole with water .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : common ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness . signs of allergic reaction may include swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 23 microgram ) glycopyroniumbromide , equivalent to 50 microgram ( 23 . 5 microgram ). - the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is approximately 44 microgram / ml of solution for inhalation . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate ( see section 2 under ' important information about some of the ingredients '). what is enure
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the target protein , riximyo helps to improve the response of the immune system . this target protein is found in large amounts in certain types of a very small number of a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the body ' s immune system ) and b ) a ) a
do not use riximyo : - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have a severe active infection at the moment - you suffer from a weak immune system ( e . g . severe heart failure or severe uncontrolled heart disease ) - you are suffering from granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus
you will be given riximyo under the supervision of a doctor who is experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may decide to change your dose . your doctor will decide how many treatments you will receive . your dose will be decided by your doctor using a drip ( intra - venous infusion ). medicines given at the time of each dosing before each rriximyo administration you will also be given other medicines ( premedication ) to reduce the
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of dl ( 3 . 0 mg / l ). - the other ingredients are : sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 " rixamyo contains sodium "), water for injections and solvent for infusion . see section 3 for further information . pack sizes of 1 and 2 vials . not all pack sizes
topotecan actavis is a medicine that contains the active substance topotecaan . it is used to treat the following conditions : - small cell lung cancer that has come back after chemotherapy - advanced cervical cancer that cannot be treated by surgery or radiotherapy . in this case topotecen actavis treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topoteecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you are breast - feeding . your doctor will check your blood cell counts if they are too low . this may be a sign that you may need to stop using toprotecanactavis . - you have or have had any kidney problems . if any of these apply to you , tell your doctor before you are given this medicine . if you think any of
the dose of topotecan actavis you receive will depend on the disease being treated and on results of blood tests carried out before and during treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . for cervical cancer , the usual starting dose is 0 . 75 mg per sqilmette of bodysurface area once a day for 3 days . your doctor may change the dose depending on your kidney function . for the treatment of cervical cancer in combination with another anticancer medicines
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following signs of infections : very common ( may affect more than 1 in 10 people ): fever . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation may affect up to 1 in 1 , 000 people : difficulty in breathing , cough and fever . this severe condition can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at ambient room temperature ( 25 ) and at 2 to 8 ° c . from a microbiological point of view , the drug product solution should be used immediately . dilution in solutions for infusion (
what topotecan actavis contains - the active substance is topotan . each vial contains 1 mg or 4 mg of topotecaan ( as hydrochloride ). after reconstitution with 1 ml of solution , 1 mg / ml contains 1 % of the solution . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see section 2 ). what topontecan effectavis looks like and the contents of the pack topotican actedavis is supplied in glass vials with grey bromobutylic stopper
ralgmine hexal contains the active substance rivastigmine ( also called cholinesterase inhibitors ). in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivaldigmine works by blocking the enzymes that break down and break down acetylecholine : acetylchlorolinescerase and butyrylcholinestersterase . by blocking these enzymes , rvelastig
do not take rivastigmine hexal : - if you are allergic to the active substance in this medicine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have had a previous skin reaction ( allergic contact dermatitis ) - you are breast - feeding . if you think any of these apply to you , tell your doctor or pharmacist as soon as possible . you are not likely to be given the medicine if you have : - an active stomach ulcer - difficulties in passing urine - seizures -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose that should be taken is 6 . 0 mg per kg of body weight each day . you should continue taking this medicine until your doctor tells you otherwise . if you have not taken rivasta hexal for more than three days , do not take the next dose until you have talked to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below have occurred with rivastigmine hexal : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite
keep this medicine out of the sight and reach of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store below 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivetigmine hydrogen tartrate . - the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ) and shellac . each rivanette hexal 1 . 5 mg film - coated tablet is engraved with the code " rv1 " on one side and the number " 3 " on the other side . - there is no information on the amount of riv
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adult patients with kidney cancer ( renal cell carcinoma ), liver cancer or a specific anticancer medicine containing sorafenib . cabometyx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , it can kill high amounts in cancer cells . your doctor will test for these changes . if you have any questions about how cabometx works or why this medicine has been prescribed for you ,
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabometx : if you have high blood pressure , have or have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall , have diarrhoea , have recently had significant bleeding or surgery within the last month , have had surgical procedures or dental surgery , have inflammatory bowel disease , crohn ' s disease , ulcer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . this medicine is for oral use . swallow the tablet whole with a glass of water . you can take cabometyx with or without food . try to take your daily dose at about the same time each day . it is important that you continue your treatment until your doctor tells you otherwise . you may experience serious side effects . duration of treatment your doctor will tell you how long you should continue to take cabometyx . the usual starting dose is 60
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects get serious or if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea , feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling
what cabometyx contains - the active substances are cabozantinib ( s ) and malate . each tablet contains either 20 mg cabozatinib or malate ( as mesilate ). each tablet of cabometx 20 mg contains caboz antinib / malate and is suitable for patients weighing 40 kg or more . - the other ingredients are tablet core : microcrystalline cellulose ( e460 ), lactose anhydrous , hydroxypropyl cellulose , croscarmellose sodium ( e468 ), colloidal silicon dioxide ahydrous and magnesium stearate ( see
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . your doctor will decide on the most appropriate treatment for you . the combination of pemetrewn hospira and cisplin is also used for the initial treatment of patients with advanced stage of lung cancer . when you first start treatment with pemetemetrex
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to any of the active substances or any other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetreedospira . if you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have or have had problems with your kidneys . before you are given pemetretted hospir you will have an infusion of your blood to check that your kidney and liver
the dose of pemetrexed hospira that you will receive is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of the body . your doctor will use this body surface area for the first three months of treatment , depending on your blood cell counts and on your general condition . if you have any further questions on the use of this product , ask your doctor . the hospital pharmacist or nurse will have mixed the pemetreedospira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death : if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction ( common ). if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of infusion solutions of pemetrexed were demonstrated for 24 hours at 2ºc - 8ºc and at 25ºc . from a microbiological point of view , the product is a sterile , colourless solution . if not used immediately ,
what pemetrexed hospira contains the active substance is pemetreepentahydrate . one vial contains 100 milligrams ( millilitres ) of pemphrexed ( as pemetretrexed disodium hemipentahhydrate ). one glass vial provides a total of 500 milligram ( milliliter ), corresponding to a concentration of 500 micrograms / millilitre of pemetereepenthydrate in each ml of solution . the total recommended dose for patients with a body weight of 1 , 000 kg or less is 1 ,000 millgrams
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by interfering with a prostaglandin analogue ( see section 2 " ganfort is a medicine used to treat glaucoma ") gansfort is used in adults , adolescents and children aged one month and older . it is used when medicines called beta - blockers have not worked well enough or are not suitable for use in children . the eye is a clear , watery liquid that is
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing , and long - standing cough ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have or have ever had coronary heart disease ( symptoms include chest pain , tightness , breathlessness , choking ,
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment should be started by a doctor or nurse . keep the bottle tightly closed in order to protect from moisture . do not put the bottle near your neck . 5 . gently squeeze the bottle . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid until there is a small pocket . 3 . put your eye back in place . after treatment , 4 . press down on the lid of your eye ( picture 2 ). gently squeeze your eye with a finger until it is
like all medicines , ganfort can cause side effects , although not everybody gets them . your doctor will tell you what dose of the drops to take . the following side effects have been reported in association with the launch of the first two doses of the second one of the third cycle of the fourth cycle ( single - dose ). very common side effects ( may affect more than 1 in 10 people ) - the eye redness . uncommon side effects these may affect up to 1 in 9 people ( 100 patients ) - sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special storage conditions . for prevention of eye infections , it should be used within 4 hours after first opening , even if the solution is clear and colourless to slightly opalescent . if you notice any change in the appearance of the solution , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol ( 5 mg / ml ). - the other excipients are : - the solvent is : - sorbitol maleate , 6 . 8 mg benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what gansfort looks like and contents of the pack the clear , colourless to slightly yellow solution for injection
gefitinib mylan contains the active substance gefitinib . it works by blocking a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells . in this way it helps to stop cancer cells from growing and growing .
do not take gefitinib mylan - if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have or have had any other lung problems . some lung problems can be serious and need immediate medical attention . your doctor may need to adjust your dose , or stop your treatment with gefnitinib melan . - have problems with your liver . your dose should be adjusted at regular intervals . children and adolescents do not give gef
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take antacids on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). try to take the tablet at about the same time each day . if you have trouble swallowing the tablet whole , talk to your doctor . do not take any other liquids until your doctor tells you otherwise . the tablet can be taken with or without food . the maximum recommended daily dose is 20 mg once a
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease ' ( i . e . uncommon , may affect up to 1 in 100 people ). gefitinib may cause severe skin reactions
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ) ( type k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what gefitoninib melan looks like and contents
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by lack or inability to receive red blood blood cell transfusions . your doctor has prescribed reblozell for you to treat anaemia in patients with mds who cannot be treated , and who may not be able to be given , or who are unable to receive ,
do not take reblozyl : if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy and breast - feeding ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot , or if preventive measures ( such as medicines ) are not sufficient . tell your doctor if you develop high blood pressure .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . how much and how often to use the recommended dose is one injection under the skin ( subcutaneously ). the dose depends on how much you weigh . the injections may be given in increments of 1 . 0 mg / kg of body weight . this dose will be adjusted by your doctor depending on your blood pressure . use in children and adolescents there is no experience with the use of the product in children younger than one year of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , and blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions including rashes 36 if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . very common side effects ( may affect more than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for a single period of up to 25 days when stored at 2 8 . from a microbiological point of view , the product should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution with eachml of solution , each ml contains 50 mg / ml of lsuspatercept ( as excipients ). - the other ingredients are citric acid monohydrate , sodium citrate , 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( ( to adjust ph adjustment ), water for injections ( see section 2 ), and ethanol ( alcohol for ethanol ) in the solvent . what rebl ozyl
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor that works by blocking the activity of a protein in the body called alpha or interleukin - 2 ( ik - 2 ). it is used to treat the cancer by stopping the growth of cancer cells and new blood vessels in patients with advanced kidney cancer who have not previously tried other treatments ( alpha or intrathecine - 2 ) which have not helped to stop your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are breast - feeding . you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have high blood pressure . your doctor will check your blood pressure before you start taking a medicine . if you think any of these apply to you , tell your doctor or pharmacist before you receive f
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of fotivda is 1340 mg twice a day ( 21 mg capsules taken 7 days apart ) taken 1 capsule of capsules taken 4 times a day . your doctor will tell you how many capsules to take each day . if you take more than the recommended daily dose , you may experience unacceptable side effects . if severe side effects occur , your doctor may reduce your dose or stop fotvda therapy completely . the usual daily dose for adults , adolescents and children
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience any of the following symptoms : severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely while you are taking fotivda . if you have highblood pressure , you may need to take a medicine to control it . your doctor will monitor your
what fotivda contains the active substance is tivozanib . each hard capsule contains 890 mg of tiv ozanib ( as tivzanib hydrochloride monohydrate ). the other ingredients ( excipients ) are : capsule content : 890 micrograms ( as talc ), mannitol ( e421 ), magnesium stearate capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ) and propylene glycol ( e1520 ) as strong ammonia solution . printing ink : shellac , propylene
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of the activity of the immune system ( the body ' s natural defence system ). both of these active substances are used to treat hiv in adults and children . each of the active substances is given as an anti - hiv medicine called a nucleoside reverse transcriptase inhibitor ( nrti ). the other active substances in stribild are tenofovir disoproxil . each is an
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . during treatment , you should tell your doctor if you have taken any medicine containing tenOFovir desoproxel . your doctor may also monitor your kidney function . these medicines may include : alfuzosin ( used to treat an
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet taken by mouth once a day . swallow the tablet whole with a glass of water . you may take your medicine with or without food . your doctor may change the dose or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ). take the tablet at least 4 hours before or 4 hours after taking stribild
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by other medicines that you are taking at the same time . these effects are usually mild to moderate . however , some hiv disease
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 micrograms of elvitagravir ( 150 mg mg mg ), cobicista , 200 mg of emptricitonabine ( 245 mg ) and ten ofovir disproxil ( 300 mg ). - the other ingredients in the tablet core are : capsule - shaped tablet ( e460 ), tablet core ( e464 ), croscarmellose sodium , hydro
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria , which has been reported in some patients taking zyprixa . it has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . if you have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before you are given this medicine . if any of these apply to you , tell your doctor , pharmacist or nurse before being given zzyprexa
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets are for oral use . swallow the tablets whole with a glass of water . your doctor may increase your dose from 5 mg to 20 mg once a day depending on your symptoms . you should swallow the tablet whole with some water . do not chew , crush or split the tablet . if you take more zkyprexa than you should if you accidentally take too many of your tablets , contact a doctor or the nearest hospital straight away . if possible , show them the pack of z
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . zyprexa will be stored by the health professionals at the hospital or clinic . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zzyprexa tablet contains either 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg . - the other ingredients in your zypxa tablet pack are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ) and carnauba wax . the different zyprixa tablet strengths are marked with the following symbols : - zy
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein . it is used to prevent bone loss in adult patients with osteoporosis when treatment is contraindicated or inadequate . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen that is made in the bones after the menopause . as a result of this , your body can no longer make enough oestrogens , and bones become thin and fragile . how prolia works and why it has been prescribed for you
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor straight away . before you are given prolia , you may develop a skin infection with symptoms such as a swollen , red area of skin on one side of your leg that feels hot and tender ( cellulitis ). symptoms include fever . these symptoms may be due to
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . one pre - filled syringe contains 60 ml of solution for injection , which should be given within 6 hours . it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . if you use more prolia than you should if you think you may have injected too much prolia , tell your doctor , pharmacist or nurse . you may also be asked to wear stickers to remind you to take calcium and vitamin d supplements .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you notice any of the following skin infections ( cellulitis ). these symptoms may be due to prolia : swollen , red area of skin ( usually in the leg ), which feels hot and tender . symptoms may include fever ( see section " warnings and precautions "). if any of these symptoms occur , stop taking the medicine and contact your doctor immediately . pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness or a feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of your pre - filled syringe after exp . this medicine does not require any special storage conditions . you may remove prolia from the refrigerator and keep it at room temperature ( not above 25 ) for a single period of up to 30 days after it is first given , but do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . each 1 ml pre - filled syringe contains 60 mg of denosumaab at a concentration of 60 mg / ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear , colourless to slightly yellow solution for injection in a clear to slightly opalescent , single - use pre -filled syringe with a needle guard .
aimirix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus can infect any part of the body , including faeces , serum or saliva . symptoms occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches and pains , feel very tired , dark urine , palefaeces or yellowish skin or eyes ( jaundice ). the severity and type of symptoms vary from person to person . all symptoms can occur
you should not be given ambirix if you are allergic to any of the active substances or any other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you think you may have been in any of these situations , tell your doctor straight away . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any vaccine for hepatitis a or hepatitis b diseases if you have a severe infection with a high temperature . the vaccine should be given at the same time as a minor infection such as
always use ambirix exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one injection into the muscle ( usually in the upper arm ). your doctor may decide to inject ambirux directly into a vein . the injection may be given into the thigh muscle . you will receive a total of two injections . the injections should be given within 12 months of the first injection . the second injection can be given between 6 and 12 months after the first . you may receive extra doses to make up for any missed doses . future booster dosing may be continued if you
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where the
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( equivalent to hepatitis b surface antigen ). 20 the other ingredients are human diploid ( mrc ), cells , aluminium hydroxide ( hydrated 0 . 05 %), saccharomyces cerevisiae , aluminium phosphate ( 0 . 4 %), sodium chloride , and water for injections . what ambiraix looks like and contents of the pack suspension for injection in a pre - filled syringe is a white , slightly milky liquid , supplied in a glass vial containing 1 ml of
besero is a meningococcal group b vaccine . bexsero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping to prevent the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine if : you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to postpone the vaccination until recovery . you have haemophilia a or any other problem that may prevent your blood from clotting properly . you are treated with blood thinners ( anticoagulants
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection ( 5 ml ) in the muscle of the thigh or upper arm . the first two injections will be given at least 2 months apart . the interval between injections should not exceed 1 month . if you miss an appointment to receive the vaccine , you may receive an additional injection ( booster ) at the time of the first injection ( see section 2 ). if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . children and
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of the injected site . other side effects may occur with this vaccine : common : may affect up to 1 in every 10 people : fever , loss of appetite , tenderness on the injectionsite ,
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein ( 1 , 2 , 3 , 50 micrograms ) and recombinant neoisseria manningitidis ( group b naa protein ). the other ingredients are : 1 and 2 , each containing a minimum of 50 international units ( iu ) of protein ( nhb ). recombinant neutrino group b fhbp fusion protein is produced in recombinant dna technology . the following substances are excipients of recombinant nhhba ( neisserial heparin
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . due to this disease your body cannot break down the amino acid tyrosine ( amino acids are substances in the body that are important for breaking down substances such as sugar , fat , water , and sugar ). your body can also break down too much of these substances , resulting in harmful substances . your doctor has prescribed this medicine to reduce the amount of tyrosrine in your body . low ty
do not take nitisinone mdk - if you are allergic to ninone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy and breast - feeding you should tell your doctor if you have had or are planning to have a baby . your doctor may decide to monitor your eyes during and up to six months after nitis inone treatment . if you develop red eyes , your doctor should examine your eyes immediately . you may need an eye examination . eye problems due to inadequate dietary control ( see section 4
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended starting dose is 1 mg for every kg of body weight . this dose may be increased to a maximum of 20 mg for this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your doctor immediately . if possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening : store in a refrigerator ( 2 8 ). do not freeze . store in the original package in order to protect from light . after opening : use within 2 months at a temperature not above 25 . store at 2 to 8 for a single period of up to six months . discard any unused medicine after this period of time .
what nitisinone mdk contains - the active substance is nisinone . each hard capsule of nitis inone dmdk 2 mg contains 2 mg ninone ( as mesilate ). each soft capsule on the other side of the capsule ( s ) contains 5 mg nitishinone . the hard capsule in the body ( s) contains 10 mg of nitesinone in the form of capsules . - the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ) and shellac glaze ( e1520 ) to help preserve the hard capsules . what
docetaxel accord will be given to you by a doctor or a nurse . the name of the medicine is debossed on the carton and on the label of the vial after ' doc ' ( the abbreviation for ' taxoids ') in your name and the number of tablets you take each day . docetaxell accord has been prescribed for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer in adults with advanced breast cancer . the other treatments are docetxorubicin , trast
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docepaxel or to any of the other ingredients of docetxel accord ( listed in section 6 ). - if your number of white blood cells is too low . if you have a severe liver disease . warnings and precautions before you are given this medicine , you will have blood tests to check that you have enough blood cells and that your liver is working properly ( see section " warnings and measures "). during treatment , you may experience : - an increase in the number of red and / or yellow blood cells . - a decrease
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxell accord is given as an infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . based on the results of your blood tests , your doctor may change the dose and frequency of dosing depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel accord may be increased when docemetaxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . after dilution , the medicine should be transferred from the infusion bag and used within 6 hours ( corresponding to 25 hours of infusion ). the infusion solution should be used immediately . non - pvc bags may be stored for up to 48 hours at 2 to 8 . if not used immediately , in - use storage times and conditions prior to use are the responsibility
what docetaxel accord concentrate for solution for infusion contains 20 mg film - coated tablets : each ml of concentrate contains either : 20 mg docelaxel in 1 ml of solution , each 20 mg / ml film - coating tablet ( tablet ) contains : 80 mg docetayel in 8 ml solution for injection , each 160 mg / l film coating tablet : docetaceel in 4 ml clear to opalescent , colourless to pale yellow to brownish - yellow solution . the other ingredients are ethanol anhydrous ( see section 2 under ' docel accord contains ethanol '), citric acid anhyd
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that stimulate the brain to produce dopamine ( a chemical in the brain ). this medicine helps to stop people from becoming impulsive , hyperactive or whatever they are being controlled with . your doctor has prescribed this medicine for you in order to treat ' attention deficit hyperactivity disorder ' ( adhd ) when current stimulant medication is not controlling adhd symptoms . the medicine is used together with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is used in adults 38 years of age and older with ad
do not take intuniv - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have low or high blood pressure - you suffer from heart problems . if you have heart problems , you have ever fainted or have recently had thoughts or feelings of suicide . - you are suffering from any other psychiatric conditions ( withdrawal symptoms , for example increased heart rate ). - you drink alcohol excessively ( either every day or only from time to time ) - you smoke . -
your treatment should be initiated under the supervision of a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will determine the dose that is right for you . the dose will depend on your condition and your response to your treatment . the starting dose is 1 tablet per day . depending on how you respond to treatment , your doctor may increase your dose to 0 . 05 mg / 0 . 12 mg twice a day depending on your bodyweight . the first
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and seek medical help immediately . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). your doctor may decide to reduce your dose or stop treatment
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister pack after exp . this medicine does not require any special storage conditions . the tablets should be used within six months of first opening . blister pack : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains - the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine ( see section 2 under ' important information about some of the ingredients '). - the other ingredients are : - in the prolonged release tablet : see section 3 under ' some of these ingredients ' for further information . - in addition , the following modified - release tablets are also available : - when you start to increase your dose , guanofacine can be kept at room temperature ( up to 30 ) for a maximum of 3 weeks . - when your dose is increased to
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections by preventing them from growing . they also prevent fungal cell walls from breaking down and infecting healthy cells . ecalda works by blocking the growth of these cells . it is used in adults where the number of
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ecaltra . your doctor will check your liver function . if you have liver problems , your doctor may decide to delay your treatment with anaesthetics or interrupt your treatment . tell your doctor if you experience an allergic reaction such as itching , wheezing or blotchy skin . an infusion related reaction may include a
how much ecalta is given the treatment will be given to you by a doctor or nurse who is experienced in the use of this medicine . the recommended dose is one 200 mg / 100 mg tablet once a day . children and adolescents ( aged 1 to 18 years ) the recommended starting dose is 3 . 0 mg / 200 mg twice a day , given as 1 . 5 to 100 mg per day . depending on the patient ' s weight , the dose may be increased or decreased depending on your condition and your general condition . when you will receive ecaltva , it is given as slow infusion ( a drip into a vein
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - potentially life - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheeezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypokala
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . the infusion solution may be stored at ambient room temperature ( up to 25 ) for up to 48 hours or at room temperature
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of an idulafugin . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and 30 micrograms / ml ( 0 . 5 %) solution for injection in a vial ( see section 2 ) for further information on the contents of the vial , see section 3 ). what Ecalta looks like and contents of this pack ecaltfa is supplied as a box containing 1 vial
adenovi contains the active substance rurioctocog alfa pegol , which is produced by recombinant dna technology using pegylated human coagulation factor viii ( rvviii ). rviii is produced in the body by biotechnology and is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v iii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in patients 12 years of age and older and in children and adolescents from birth to adulthood . in this age group , haem
do not use adynovi if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using adynov : if you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction ) to any ingredient contained in the medicine , or if you notice any unusual signs of allergic reactions such as rash 95 , hives , wheals , generalised itching ,
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the most appropriate dose for you . the dose you receive will depend on your condition and the type of bleeding that you are suffering from . your physician will determine the dose that is right for you and will decide if you should be treated with adsynovi . the replacement therapy will be given to you by your doctor or nurse . how often to use your doctor may decide to give you a higher or lower dose depending on how you respond to the treatment . how much adyn
like all medicines , this medicine can cause side effects , although not everybody gets them . if sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms such as difficulty in breath or fainting occur , prompt emergency treatment is immediately available . patients who have received previous treatment with factor viii ( more than 150 days of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . the powder vial may be kept at room temperature ( up to 30 ) for a single period of up to 3 months . after this period , this medicine expires at the end of this 3 - month period or it may be stored at a temperature below 30 for a maximum of 3 months , whichever is earlier
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of the active ingredient , as measured in international units ( iu ) per ml . - the other ingredients are : powder vials : pregelatinised water for injections , mannitol ( e421 ), trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride diydrate , tris ( hydrox
rekovelle contains follitropin delta , a follicle stimulating hormone ( fsh ), which belongs to a group of hormones called gonadotropins . fsh is a natural hormone produced by the body and belongs to the group of gonadotropic hormones that play an important role in female fertility . recovelle is used in women undergoing assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ( intr ) in order to stimulate the ovaries to produce many egg sacs .
do not use this medicine if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before using rekovelle . warnings and precautions you should tell your doctor if : you have or have had your fertility problems before . you are allergic to follicle stimulating hormone ( fsh ). you have enlarged ovaries or cysts on your ovaries . you have polycystic ovarian disease ( bleeding from the vagina at an early menopause ) or malformations of the sexual organs ( see section " pregnancy and breast - feeding "). you have fibroids of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will prescribe a type of anti - müllerian hormone to stimulate your ovaries to produce stimulation with gonadotropins . the dose is based on your blood weight . a blood sample taken during the last 12 months of treatment will be taken to work out the dose you need to receive . your dose will depend on your body weight . duration of treatment your doctor may decide to increase or decrease the dose of the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones ( infertility ) this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( the frequency cannot be estimated from the available data ) ovarian hyper stimulation syndrome ( pelvic pain or discomfort ) ovarian origin tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . rekovelle may be stored at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months at 28 to 25 . during the treatment
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of follitroin delta in 0 . 36 millilitre of solution . after reconstitution , each ml of solution contains 33 . 3 milligrams of follnitropin delta in each millilitere of solution ( corresponding to 0 . 35 millilitres of solution ). - the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahhydrate , concentrated phosphoric
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation contains either of these active substances . the recommended dose for adults , adolescents and children aged 12 years and older is : - one inhalation twice a day ( morning and evening ). - two inhalations once a day , at about the same time each day , are used to reduce the effects on the body of the two active substances in the treatment of asthma . the dose should not exceed 184 mg / 22 . for adults and adolescents aged 92 / 22 who have chronic obstructive pulmonary disease ( copd
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ellipta . ellipta has not been studied in patients with liver disease . it is not known whether ellipta causes side effects . if you have moderate or severe liver disease , your doctor may lower the dose of the lower strength of ellipta to 92 / 22 mg . tell your doctor if : you have heart problems , high blood pressure , tuberculosis (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the recommended dose for asthma is one inhalation twice a day ( morning and evening ) with fluticasone furoate and 22 mg vilanterol . for severe asthma , your doctor may prescribe the higher strength inhalation ( two inhalations once a day ) of fluticasafuroate ( 22 mg per day ) and vilancerol . copd the recommended starting dose for copd is one and a half inhalations ( morning , evening and evening
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , sometimes of the face or mouth ( angioedema ), feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties if you have immediate breathing problems while taking revint
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation provides 92 microlitres of the two active substances respectively , for the treatment of patients with chronic obstructive pulmonary disease . - the other ingredients are : - for adults , the 92 dose is as follows : - as a single inhalation , the dose is either as a 22 microlitre dose , as a 28 microgram dose , or as a 4 microgram tablet , as as a 6 microgram acute dose . - for children weighing less than 22 kg ,
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine ( also known as a nucleosidermal necrolysis ( nrti ) and tenofovir ( a nucleotide reverse transcriptase inhibitor ). these active substances belong to a group of antiretroviral medicines which work by interfering with the normal working of an enzyme ( reverse transcriptases ) that is essential for the virus to multiply .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects ( such as dizziness and drowsiness ) have been reported . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take the amount of tablets to take varies depending on your condition . your doctor will tell you exactly how many tablets to
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately
what atripla contains ∑ the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atrippla film - coated tablet contains 600 mg of the two active substances , efavenirenz and 200 mg of emptricitonabine . ∑ each tablet contains 245 mg / ml of the three active substances, respectively , of the four substances , as ten ofovir dissoproxel ( as fumarate ). ∑ ∑ − the other ingredients are : tablet core : croscarmellose sodium ,
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin ( gnrh ), which is a synthetic version of the natural gonadonrophin releasing hormone ( ngrh ). gnrh regulates the release of gonadsotrophins and follicle stimulating hormone ( fsh ) by the female sex hormones ( dna ). gonadotropins play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells in the
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive ( hypersensitive ) to gonadotrophin releasing hormone ( gnrh ), a gnrh analogue . if you have a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you must tell your doctor if you develop an active allergic condition . your doctor may recommend additional monitoring during treatment . allergic reactions if you experience allergic reactions ( generalised ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran should only be given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ), on day 2 or day 3 of each treatment cycle . you will be given one injection of the medicine as an injection under the skin ( subcutaneously ), followed by one injection every 5 to 6 weeks . your doctor may decide to change the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect very common ( may affect more than 1 in 10 people ) local skin reactions ( e . g . redness and swelling ). the local reaction usually disappears in about 4 to 1 in 100 people . headache , nausea , malaise ( rare ) may occur very rarely ( less than 1 per 10 , 000 people ). allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , which may cause difficulty in breathing or swallowing ( angioedema
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). syringes should be clear , solvent - free solutions . store below 25ºc and do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ) and water for injections ( see section 2 ). - the ph is sodium hydroxide ( e524 ) which is used to adjust the amount of acic acid in the vial . see section 3 " what you need to know before you start using orglutran " for further information on the contents of this pack . what it looks like and contents of the pack ganirutran is a clear ,
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". when a stick to the target , the cell dies . how blitzima works blitzima can be used to treat : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the immune system ) in adults . b ) a very small number of a type ( called a - lymphocytes ) have been removed from the
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using blitzima if you : - have a severe active infection - have had a weak immune system - have severe heart failure or severe uncontrolled heart disease - have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section " other medicines and blitzima "). -
how blitzima is given this treatment will be given to you by a doctor or nurse who is experienced in the use of this medicine . they will watch you closely while you are being given this medicine , in case you experience any side effects . how is blitzima given - the first dose is given as a drip ( intravenous infusion ). - your doctor will prescribe medicines for each blitzima administration . - during treatment with blitzima , you may be given other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you have non - hodgkin ' s lymphoma you will receive one
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light .
what blitzima contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). - the other ingredients are : 50 mg or 500 mg ( 1 ml of solution for infusion ) see section 2 : what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for injection or infusion . it is supplied in glass vials containing 2 ml , 50 ml or 1 glass vial . not all pack sizes may be marketed .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a protein that recognises and attaches to a specific target in the body ). it works by blocking the activity of a protein called interleukin - 6 , which is involved in causing the inflammation in your body . by blocking this protein , roactenra can cause symptoms such as pain and swelling in your joints . roactema reduces the damage to the cartilage and bone in the joints caused by the disease , and improves your ability to do normal daily activities and to carry out normal daily tasks . ro
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor , pharmacist or nurse before using the infusion . if you think any of these apply to you , tell your doctor or nurse straight away . you may need urgent medical attention if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash . the infusion may need to be slowed down or stopped .
always use roactemra exactly as your doctor has told you . you should check with your doctor or nurse if you are not sure . the intravenous infusion is for single use only . your doctor will decide how long you should receive the treatment . how much to use the recommended dose is roactema 8 mg once a day for 4 weeks . the recommended starting dose is 8 mg per kg of body weight . you will only be treated once every 8 weeks . how long to use your first dose of roctemra will be given as 4 mg given as a drip in the vein ( intravenous infusion ). the
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients taking the medicine ( see section 3 " warnings and precautions "): very common side effects ( may affect more than 1 in 10 people ): allergic reactions such as difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections such as fever and chills , mouth or skin blisters and stomach ache signs and symptoms of liver toxicity ( rare , may affect up to 1 in 1000 people ): tired
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions .
what roactemra contains the active substance is tocilizumab . each ml of solution contains 4 mg of 80 mg of tociluzumab ( 20 mg / ml ). each 10 ml vial contains 200 mg of the other ingredients ( see section 2 ). the other ingredient ( s ) are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactoremra looks like and contents of the pack roactamra is a clear , colourless to pale yellow concentrate for solution for infusion . ro
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . onbrez bronz inhaler is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles , making it easier for air to get in and out of the lungs when you breathe in .
do not use onbrez breezhaler if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before using onbrezer if you : have heart problems . have epilepsy . have thyroid gland problems ( thyrotoxicosis ). have diabetes . if any of these apply to you , tell your doctor or pharmacist before using this medicine . if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these may be signs
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the usual dose is one 150 microgram capsule once a day . your doctor may increase your dose to 300 micrograms once daily depending on how you respond to the treatment . you should use your inhaler at least 24 hours after using onbrez breezhaler . how to use an inhaler and capsules ( in blisters ) the medicine is inhaled using inhalation powder provided in the pack . you will need to use one inhaler twice a day for 24 hours
what onbrez breezhaler contains - the active substance is indacaterol . - each hard capsule contains 150 micrograms of this medicine . - the other ingredients ( excipients ) in the capsule are lactose and the capsule is made up of gelatin . one hard capsule ( 300 microgram ) contains indiacaterol ( as excapients ). - the printing ink in the capsules is made of gelatin and is supplied as an inhaler . capsules are provided in blisters . the capsules consist of a white powder and are supplied in a clear plastic bottle . - on brez breezyhaler
clopidogrel hcs belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thromboembosis ). clopidogsrel clcs is taken by adults to reduce the number of bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombosis , which
do not take clopidogrel hcs - if you are allergic to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer , bleeding within the brain or severe liver disease . if this applies to you , tell your doctor . warnings and precautions the following apply to you and your family : if you think any of these apply to your ( or you are in any doubt at all ) situation , talk to your doctor or pharmacist . you should not take
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower dose ( up to 300 mg of one 75 - day treatment course of 75 days ). if you take more clop
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel hcs contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). - the other ingredients ( excipients ) are ( see section 2 ' clopide contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if : you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). you have severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . your doctor may need to change your dose of fetcro
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how fetcroja is given it is given as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 hours . your doctor will decide how many treatments you need and how often you need to use it . the duration of your treatment depends on the type of infection you have and whether your infection is getting worse . you should not experience any pain during the fetcroja infusion . it is recommended that you never inject yourself into another vein . if you have kidney problems if
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction - sudden swelling of your lips , face , throat or tongue - a severe rash or other severe skin reactions - difficulty swallowing or breathing - signs of this reaction may include diarrhoea , stools , blood or mucus . treatment may be stopped or medicines given to slow bowel movement ( see section " warnings and precautions "). other possible side effects talk to your doctor , pharmacist or nurse if you
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ccfiderocol . - the other ingredients are sucrose , sodium chloride , and sodium hydroxide . what fetcroJA looks like and contents of the pack fetroja is a white to off - white powder for concentrate for solution for infusion . it is available in packs containing 10 vials .
depocyte is used to treat a condition called lymphomatous meningitis in adults , adolescents and children aged 2 years and above . lymphoma tumour cells are found in the membranes of the brain and spinal cord . depocyte works by blocking their growth and division . by blocking this process , depocyte reduces the growth and spread of lymphoma cancer cells .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using depocyte if you have a meningeal infection . severe neurological side effects during treatment with depocyte you may experience symptoms related to the nervous system such as convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop using any dexamethasone tablets and tell your doctor immediately . unwanted effects your doctor will monitor your side effects
there are strict laws on the use , handling and disposal of cancer in the lumber sac . depocyte will be given to you by a doctor or nurse trained in the use of depocyte . the recommended dose is one vial of 1 mg or 5 mg of dexamethasone per 5 ml of body weight . each depocyte dose will be monitored by your doctor to detect any side effects . your doctor will decide how much depocyte you should receive . the dose will depend on body weight , body surface area ( temperature 22 to 30 ). before withdrawing depocyte from the vial , make sure that proper precautions are taken
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss possible side effects with you and will explain the risks and benefits of your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 people very rare : may affects less than 1in 10 people reporting of adverse events if you get any side effects after receiving depocyte , talk to your doctor or pharmacist . depocyte
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . depocyte must be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . alternatively , depocyte may be stored at room temperature ( up to 25 ) for up to 4 weeks in the outer carton . once depocyte has been removed from the refrigerator , the product must be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . do
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytarbine . one vial of 5 ml solution contains 50 mg ( 1 . 5 mg / ml ). - the other ingredients are cholesterol , triolein ( e331 ), dioleoylphosphatidylcholine ( e339 ), dipalmitoylophosphATidylglycerol ( e507 ), sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution for injection . it is supplied in a
mrist breezhaler contains two active substances , indacaterol and mometasone furoate . both of these active substances are used to treat asthma in adults . both belong to a group of medicines called bronchodilators . they work by relaxing the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs and making it less likely that you will have to go to the hospital . both active substances work in different ways to help the smaller airways to remain open and air to be breathed in .
do not use bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have heart problems , have an irregular or fast heartbeat , have thyroid gland problems , or have diabetes , have high blood sugar , have seizures , have a low level of potassium in your blood , have severe liver problems or have tuberculosis ( tb ) of the lung
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules are for oral use only . swallow the capsules whole with a glass of water . you can take the medicine with or without food . do not open or crush the capsules . if your asthma does not improve or your symptoms get worse , talk to your doctor . how to use and use the spray bottle with your new inhaler . how much to use bemist breez inhaler is a clear , colourless to pale yellow solution . you will find bem
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( might affect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( sign of angioedema ). other side effects other possible side effects are listed below . very common : may affect less than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light and moisture . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) ranges from 125 to 62 . 5 micrograms of each inhalation , corresponding to a concentration of 173 mg / ml of solution for injection each day . - the other ingredients ( excipients ) are : tablet core : indaconaterol , 150 mg / kg of solution per inhalation . tablet coating : indiacaterol and 80 mg / cm of solution . momet
the active substance of zyllt , clopidogrel , belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zylltic is taken by adults to prevent blood clumps ( thrombi )forming in hardened blood vessels ( arteries ), a process known as atherothrombinosis , which can lead to atherotrombotic events ( such as
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist , or nurse before taking zllt : if you think you may be at an increased risk of bleeding , such as : - if you already have a risk of internal bleeding ( such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose of 300 mg of zllt ( 1 tablet of 75 mg ) once at the start of treatment . then , the usual dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' zllt contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what
lamivudine teva contains the active substance lamivudrine . lamivuda teva is used for the treatment of long term ( chronic ) hepatitis b infection in adults , adolescents and children aged 12 years and older . lamvudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver , and so is life - threatening . in patients with long term (" chronic ") infection , liver damage is increased . your doctor
you must not be given lamivudine teva : - if you are allergic or breast - feeding . warnings and precautions 28 talk to your doctor , pharmacist or nurse before you are given this medicine if : - you are breast feeding , as this medicine may cause serious side effects . - you have liver disease , such as hepatitis c . you are overweight . - your doctor will do blood tests before you start your medication . see section 4 for more information . if you think any of these apply to you , tell your doctor or pharmacist . before you receive lamivuda teva , your doctor may check your hepatitis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you keep taking it every day until your doctor tells you otherwise . your doctor will check whether your infection is getting worse and will treat your illness if necessary . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how long to take lamivuda teva the recommended starting dose is one tablet a day . if lamiv
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of lamivudine teva are related to other conditions linked to hepatitis b . the following side effects have been reported during therapy for ' hepatitis b ' in clinical trials : the most common side effects reported during lamvudine clinical trials were tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting and diarrhoea . increases in liver enzymes ( a type of enzymes found in the muscles ). allergic reaction ( rare , may affect up to 1 in 1 , 000 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamvudine . each film - coated tablet contains 100 mg of lamludine - the other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and iron oxide red ( e 172 ). what lamivuda teva looks like and contents of the pack orange , round , biconvex film , debossed with
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms can include fatigue , weakness and shortness of breath . it is caused by the lack of the natural hormone erythropoietin ( a substance produced by your kidneys ). your bone marrow does not produce enough redblood cells . your doctor has prescribed darbepoetin alfa for you to treat chronic renal failure . symptomatic anaemia can occur if : you have kidney failure . kidney failure occurs when the kidney is not working properly . your
do not use nespo if you have high blood pressure or are taking other medicines . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using neespo ( darbepoetin alfa ) or r - huepo : if you suffer from any of the following conditions : highblood pressure , medicines to treat sickle cell anaemia , epileptic fits ( seizures ), convulsions ( fits ). seizures have been reported in patients with liver disease . drugs to treat anaemia have been associated with an allergy to latex
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight . if you are not sure about this , talk to your doctor or pharmacist . the dose may be increased or decreased depending on your condition . if your doctor determines that you do not have enough of the hla - b * 5701 gene , you will be given a single injection under the skin or into a vein ( intravenous ). if your anaemia
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported : very rare ( may affect up to 471 in 10 , 000 people ) - high blood pressure ( hypertension ) - fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 people ) not known ( frequency cannot be estimated from the available data ) - formation of blood clots ( thrombosis ) - pain in the area injected rash , redness and / or the skin rare : may affect less than 1 in 10, 000 people - serious allergic reactions - sudden life
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the label of the syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening : do not store above 30 and keep it at room temperature ( not above 30 ) for a maximum of 7 days . keep the bottle tightly closed to protect it from moisture . you should not use neespo if you notice particles in it . medicines should not be disposed
what nespo contains the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms . the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic ( e1200 ), sodium chloride , polysorbate 80 and water for injections . the solvent is a clear , colourless to slightly pearly liquid and not cloudy . 1 ml solution for injection is available in packs containing either 1 or 4 pre
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used in adults , adolescents and children under the age of 18 years to treat the following conditions : the treatment is usually started by a doctor who has been trained in the use of this medicine . people with this disease have vision loss caused by damage to a part of the retina called the macula . macula is the thin layer at the back of the eye ( amd ). abnormal blood vessels grow in the retina
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you may have an infection or bleeding in the eye , stop macugen injection and contact your doctor immediately if you experience the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . the injection may cause the injection to stop working
mugen will be given to you by a doctor or nurse who is experienced in giving injections of macugen . macugen is given as a single injection into the back of the eye . it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of your eye . your doctor will decide how much macugen you need and how often you need to be treated . if you are given more macugen than you should if you think you may have been given too much , talk to your doctor , pharmacist or nurse immediately . you may need to have some local anaesthetic ( numbing medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ). the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special storage conditions . the medicine should be used immediately after first opening .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains : a vial containing
palifermin belongs to a group of medicines called escherichia coli . palifermin works by blocking the growth of epithelial cells in the mouth and digestive tract , which are tissues that line the skin . by blocking these growths , the medicine helps to protect the mucosa from growing and growing in the digestive tract and tissues beneath the skin ( mucosal mucositis ). kepivance is used in adults to treat oral muositis ( soreness , dryness or inflammation of the mouth ) as an additional side effect during treatments for your blood cancer . if you have or have had problems with your blood
do not take kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children below the age of 18 years . other medicines and kepacivance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . this is particularly important if your doctor has recently changed your dose of heparin . pregnancy , breast - feeding and fertility ke
how kepivance is given your doctor will decide on the dose you will receive . the usual dose of cancer treatment for adults is one 60 mg tablet ( 0 . 5 ml ). the recommended dose for your child is one kilogram ( kg ) of body weight given as an intravenous injection into a vein . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and decrease in the amount of digestive enzymes produced in the
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see section 2 ). what kepvelance looks like and contents of the pack kepalivance is a white powder supplied in a glass vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalacet , which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . the function of these glands is to help control the level of calcium in the bloodstream ( hypercalcaemia ). it is also used in adult patients with secondary hyperparathyroidism to treat serious kidney disease who are not on dialysis or who are unable to swallow food or waste products because they
do not take cinacalcet accordpharma : - if you are allergic to the active substance cinapalcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment with cinocalcordpharma . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have : - seizures ( fits or convulsions ). seizures may be life threatening . - liver problems . - heart failure . if you think any of these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of cinacalcet accordpharma is one tablet a day . your doctor will tell you how many tablets to take and how long you should continue to take them . the tablets should be taken orally with regular blood samples . duration of treatment in patients with secondary hyperparathyroidism the recommended starting dose for adults and adolescents of 18 years and older is two tablets a day ( 0 . 20 mg twice a day ). if you have the impression that the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common : may affect up to 1 in
what cinacalcet accordpharma contains - the active substance is cinacetalcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaconep ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ) and iron oxide yellow ( e172 ). what the tablets look like and contents of the pack √calcet cordpharma 30 mg
jentadueto contains two different active substances called linagliptin and metformin . both of them belong to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which work together to reduce the amount of sugar in the blood when metformatin is taken . these are biguanides . they help to control blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or with certain other medicines used to treat diabetes (
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function or uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " risk of lacticacidosis "). what is ketoacidosis ? keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should only be prescribed to you by a doctor who is experienced in the treatment of patients who are currently taking metformin . your doctor will prescribe individual tablets of linagliptin to help you stay on the diet and exercise recommended by your doctor . do not increase the dose of both of these active substances . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor , pharmacist or nurse . the recommended dose is one
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion ( hypocaemia is a very rare , may affect up to 1 in 10 , 000 people ), but very serious side effect called lactic acidosis ( see section " warnings and precautions "). stop taking the combination jent
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . do this medicine if you notice any visible signs of tampering or if the solution is discoloured .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each dosing dose for 2 . 5 mg / 850 mg film - coated tablets is equivalent to one tablet ( 10 mg / 2 . 25 mg ). - the other ingredients are : tablet core : linaglioptin and 850 mg of metformatin hydrochloride ; tablet coating : arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by preventing hiv from multiplying and infecting other people who are infected by hiv . it is used in combination with other hiv treatments . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . if you think any of these apply to you , tell your doctor , pharmacist or nurse before you are given the medicine . you should also tell the doctor if you have recently taken or might take any other medicines : - carbamazepine , oxcarbazepine or phenobarbital or phenytoin - medicines to treat some bacterial infections ( e . g .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults ( 18 years of age and older ) the recommended dose of edurant is : 1 . rifabutin ( a medicine used to treat some bacterial infections ) your doctor will tell you if you need to take a lower dose than your doctor tells you to . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist , or nurse . edurants can be taken with or without food . 2 . taking an antacid ( a
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains - the active substance is rilpivirine . each film - coated tablet contains rilpnirine hydrochloride . each tablet of edurants contains 25 mg of rilnirine per kilogram of body weight . - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film - coating contains lactosemonohydrate , hypromellose 2910 ( e464 ) and 6
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines help to control the level of sugar in your blood when you have type 2 diabetes . people with type2 diabetes either don ' t make enough insulin or their body does not make enough of a insulin to control their blood sugar levels . the insulin that your body makes does not work as well as it should , and the body is not able to use the insulin it produces to control your blood sugar effectively . avandamanet is also a sulphonylurea ( a type of medicine used to treat diabetes
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . your doctor may need to change your dose of avandamet . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacid
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is achieved gradually over 1 to 8 weeks . the maximum dose is reached gradually over 4 weeks . your doctor will decide the right dose for you . the dose may be increased gradually over several weeks . how long to take your daily dose depends on how well your body responds to the medicine . if you have the impression that the effect is too strong or
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions have been reported in patients taking avandamanet . signs include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking the medicine and contact your doctor straightaway . lactic acidosis has been reported rarely in cancer patients taking metformin . patients with severe kidney disease have reported symptoms of lacticacidosis such as rapid breathing , cold stomach pain , nausea and vomiting .
keep this medicine out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains either : avandamanet tablets contain either : 1 mg rosIGlitazONE ( 500 mg metforma ) or 2 mg rosciglitasone 500 mg ( metformatin ). each tablet is made up of two equal doses ( 2 mg and 2 mg ). rosigllitazon and 1000 mg ( meetformin ). each film - coated tablet is also made up as 4 tablets ( 6 mg and 10 mg ). - the other ingredients are : tablet core : ro
clopidogrel mylan belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombolybosis ). clopidoggingrel melan is taken by adults to reduce the number of bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombosis ,
do not take clopidogrel mylan 31 - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopridogrelmylan : if you have an increased risk of bleeding including - a medicalcondition that puts you at risk of internal bleeding ( such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose of 300 milligrams ( one 25 mg / 5 mg tablet ), once a day , for as long as your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel mylan contains - the active substance is clopilogrel . each film - coated tablet contains 75 mg of clopiodogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopridogrel Mylan contains hydrogenatedcastor oil '); tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) with a condition called thromboocytopenia ( a medical procedure that causes bleeding ). it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not take doptelet - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have or have had blood clots in the veins or arteries ( which may increase the risk of blood cl clots ) - you are breast - feeding ( for example , if you have cancer ). - you take the contraceptive birth control pill or hormone replacement therapy . - you recently had surgery or are seriously injured . - 23 you are overweight or have advanced chronic liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . the recommended dose of your medicine is 20 mg , 40 mg , 60 mg or 5 mg per day . if your platelet counts are too low , you may have to take a smaller dose of this medicine ( 10 mg or 13 mg ) depending on the results of your planned medical procedure . swallow the tablet whole
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( likely to affect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains ∑ the active substance is avatrombopag . each film - coated tablet contains an active substance called avATrombapag maleate . ∑ each tablet contains 20 milligrams of avatrogopag ( as lactose monohydrate ). ∑ other ingredients ∑ see section 2 ∑ tablet core : microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow (
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles in the heart . rapiscan is used in adults to perform a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using the muscles of the heart using a readmill to measure blood flow . a scan can only be done if you have a small amount of radioactive material in your body . this medicine is injected into a vein ( usually by your hand ). images
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or if you are using a pacemaker . if you experience chest pain ( unstable angina ), stop treatment and tell your doctor straight away if you suffer from low blood pressure ( hypotension ), heart failure or allergic to regadenoson . children and adolescents do not give this medicine to children under 6 years of age because there is no information on its use in this age group . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if any of the following apply to you
rapiscan will be given to you by a doctor or nurse who is experienced in the care of patients with a history of problems with your heart and blood pressure . the recommended dose is one injection into a vein ( 400 mg / ml ) with a 5 ml solution the injection may be given over a period of 5 to 10 minutes depending on your weight and your general condition . your doctor may also give you an injection of sodium chloride 9 milligrams / ml ( 0 . 9 %) solution for injection for 5 minutes . if you are given a radioactive substance ( radiopharmaceutical ), the dose of rapiscan may
like all medicines , rapiscan can cause side effects , although not everybody gets them . most of the side effects are mild to moderate . however , some may be serious and require therapiscan injection lasting 30 minutes or longer . your doctor will decide whether you need any treatment . tell your doctor straight away if you notice any of the following serious side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated , and your doctor will tell you how long you should continue to take viagra as a treatment for adult men with erectile dysfunction ( impotence ). this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain ") in adults . if you are not sure , talk to your doctor or pharmacist before taking the medicines . you are also taking nitric oxide donors such as amyl nitrite , which can lead potentially life - threatening consequences if you take them , as they may increase your risk of a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 50 mg tablet once a day . viagra film - coated tablets can be taken with or without food . do not take viagra orodispersible tablets . swallow the tablet whole with a glass of water . taking viagra with food viagra may help you to get an erection when you are sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . if possible , show them
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects are usually mild to moderate . stop taking viagra and see a doctor straight away if you notice any of the following serious side effects : viagra may cause an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . if you get chest pains , try to sit or lie down in a semi - sitting position . you may need to take nitrates to relieve your chest pain . prolonged and
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinson '.
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine , if you have or have had any medical conditions , including symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa has not been studied . if you develop dysk
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for the treatment of parkinson ' s disease is 3 tablets per day . during the first week , the usual starting dose is 1 tablet ( 0 . 088 mg ) once a day . your doctor will adjust this to a dose of 0 . 264 mg twice a day ( 1 tablet ) once in the morning , then gradually increasing the dose to a daily dose of 2 tablets ( 1½ tablets ) once daily . this will be until you reach a maintenance dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( likely to affect up to 1 in 100 people ) uncommon ( likely not to affect 1 in 1 , 000 people ) not known ( frequency cannot be estimated from the available data ) very rare ( unlikely to affect less than1 in 10 , 000 patients ) with parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ) - dizziness -
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg or 0 . 35 mg , respectively ( equivalent to 0 . 7 mg / ml ). - the other ingredients are : tablet core : pramipxole ( 0 . 125 mg ), 0 . 25 mg and 0 . 5 mg dihydrochloride monohydrate . tablet coating : mannitol ( e421 ), maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . see section 2 for further information . what s
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . it is used to prevent allergic conditions from occurring in the eye . the allergic reaction may be severe and may be life - threatening . the signs may include allergic congestionivitis caused by exposure to some materials ( allergens ). allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor as soon as possible . you may feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents do not give this medicine to children or adolescents under the age of 3 years because benzalkonium chloride may be present in some of the adsorbed on the surface of the tablets when they are given emadrine ( see section 6 . clinical trials ). talk to your doctor if you think any of these apply to you . other eye drops please tell your doctor or pharmacist if you use , have recently used or might use any
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 3 drops in each eye once a day . this medicine is for use in both eyes . use in children and adolescents ( 12 years of age and older ) the recommended starting dose is one drop in the affected eye each day . your doctor will tell you how many drops to use and how long you should continue to use it . how to use use the emadine bottle : wash your hands before using it . remove the bottle from the bottle . twist off the
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects of the drops are usually mild to moderate . common side effects ( may affect up to 1 in 10 people ) effects in the eye such as eye pain , itchy eye and eye redness . uncommon side effects these may affect upto 1 in 100 people ( effects affecting the front part of the eye called corneal disorder ) abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornea staining and dry eye . general side effects such as headache , difficulty sleeping , sinus headache , bad
keep this medicine out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . store below 25 . store in the original package in order to protect from moisture and infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide , to maintain acidity levels ( ph levels ). see section 2 for further information on acidity and ph levels . what emADine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). the epilepsy is unique in that the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of that brain ( partial onset seizure , with or without secondary generalisation ). you have been given levetiraacetam in combination with
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - if your doctor has told you that you have kidney problems . - if there is any slow down in the growth or unexpected puberty development of your child . your doctor may prescribe anti - epileptics such as levetiraacetamactavis . tell your doctor if you have ever had thoughts of harming or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis should be taken once a day in the morning and once in the evening , at about the same time each day . monotherapy dose in adults and adolescents from 16 years of age and older : the usual starting dose is 1 , 000 mg twice a day . the dose may later be increased to 3 , 000 iu twice daily . your doctor will tell you how many tablets to take . if you have the impression that the effect is too strong or too weak , talk
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms with a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes ( shown in blood tests ) and a decrease in a type of white blood
what levetiracetam actavis contains - the active substance is levetoracetam . each tablet of leveturacetamactavis 250 mg contains 250 mg levetiraacetam ( as besilate ). each tablet contains 500 mg filmaucer ( as mesilate ) levetmiracetam and each tablet is approximately 750 mg ( 4 . 0 milligrams ). each dose is approximately 500 mg ( 6 . 0milligrams ) of the active substances . - the other ingredients are : tablet core : levetiroacetam 250 mg : crospovidon , povidone
the active substance umeclidinium bromide belongs to a group of bronchodilators . incruse ellipta is used to treat adults . this medicine is used for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked , leading to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medication works by tightening these muscles , allowing air to get in and out of the lungs more easily . this helps to control your breathing difficulties and reduces the effects of cop
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have asthma . this medicine should not be used in patients with asthma . - have heart problems - have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - have severe liver problems . immediate breathing difficulties such as tightness of the chest , coughing , wheez
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . use incruse ellipta every day until your doctor tells you otherwise . do not use more than the recommended dosage . if you use more incruce ellipta than you should if you think you have used more than your prescribed dose , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or whe
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are rare ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose , throat cough feeling of pressure , pain in the cheeks and forehead . inflammation of the sinuses
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the sealed tray in the outer carton in order to protect from light . after first opening of the tray , the inhaled tray should be used within 6 months . once the tray has been opened , the active substance must be removed from the tray and used within 30 . discard the tray after this time period . write the date that incruse ellipta
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms ( 0 . 5 millilitres ) umclidium . each delivered dose provides a deliverant dose of 65 microgramms ( 1 . 0 millilitre ) of umecylidinia bromides . - the other ingredients ( excipients ) are lactose monohydrate ( see section 2 under ' incrusemella contains lactose '), magnesium stearate ( e470b ) and water for injections . what
nucala contains the active substance mepolizumab , which is a monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a white blood cell that transports oxygen from the lungs to the body ) and can be life - threatening . in patients of all ages ( including those who are not able to use a regular inhaler ), nucala can be used alone or in combination with medicines called high dose
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have asthma - related side effects your doctor may want to monitor your asthma more closely while you are being treated with this medicine . if you have any further questions on the use of this type ( monoclonal antibodies ), please ask your doctor or pharmacist . severe allergic reactions to other parts of the body ( see section 4 " possible side effects "
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week ( 1 injection in the pre - filled pen ). if you have any further questions on the use of nucala , ask your doctor or pharmacist . duration of treatment your doctor will tell you how long you should continue to receive nuca . your doctor may decide to reduce the dose or stop the treatment . if you stop receiving nucal , your asthma symptoms may come back or get worse . if attacks occur , your doctor should treat your asthma
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( this may be due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the other side effects listed above . very
keep this medicine out of the sight and reach of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator at room temperature ( up to 30 ) and protected from light for a maximum period of 7 days .
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of the medicine . - the other ingredients ( excipients ) are : sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale 1 mg solution for injection in a pack is supplied as 1 ml in a multipack containing 3 ampoules of 1 ml . not all pack sizes may be
what ninlaro is and what it is used for it is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what is it used for and how does it work ? what is myeloma ? it is an advanced form of a cancer of the bone marrow . in patients with a certain form of multiple myelooma ( a disease where the immune system ( the body ' s natural defence system ) has failed to produce enough proteins to fight off the disease . how it works in people with this form of cancer , the active substances in the medicine are called proteasomes
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . do not take any more of the following : if you think any of these apply to you , or if someone else has taken your medicine , tell your doctor or pharmacist immediately . if you take more of these than you should if you have accidentally taken too many tablets , contact your doctor straight away . if possible , stop taking the tablets immediately and contact a doctor or the nearest hospital
do not take ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take more than the recommended dose of one capsule . if you cannot swallow the capsule whole , talk to your doctor , pharmacist or nurse before taking this medicine . how much to take your doctor will tell you how many capsules to take and how often you should take them . the usual starting dose of ninlar is lenalidomide and dexamethasone once a day for the first 4 weeks . your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that make you easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs orfeet ( peripheral oedema ) skin rash ( itchy all over the body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . the capsule can be removed from the blister and left at room temperature ( up to 30 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg ixasomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the printing ink contains : - the capsule content is white to off - white , printed with ' ix ' on one side and ' 3 ' on
do not use palforzia : if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfORzia . use in children and adolescents ( from 4 to 17 years of age ) the safety and efficacy of treatment in children with peanut allergy has not yet been established . peanut ( desensitisation ) has not been demonstrated in children . palfiorzia should not be used to treat allergic reactions to peanut or to food allergies . if any of the above applies to you , do not give this medicine to your child . do
do not take palforzia : if you are allergic to peanut or soya if you have severe asthma if your asthma is getting worse or you have a problem swallowing . if you suffer from long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . it may take up to 60 days before you feel better . talk to your doctor , pharmacist or nurse before you start treatment . if any of the above applies to you ( or you are not sure ), tell your doctor or pharmacist before starting treatment with palfORzia . warnings and precautions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been told by your doctor that you have allergy , allergic reactions ( anaphylaxis ) may occur within 3 months of starting treatment with palforzia . initial doseescalation and up - dosing steps your doctor will instruct you on how to follow these treatment steps . follow the instructions given at the end of this leaflet for further information . if necessary , your doctor may instruct you to take a smaller number of doses . if the initial dose escalation and subsequent doses are not
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions if you have any of the following symptoms after taking palfORzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing , or speaking - changes in voice , dizziness or fainting , severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin pimples , problems with the stomach and digestive system ( eosinophilic o
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store below 25 . store in the original package in order to protect from moisture . this medicine must not be used if you notice any hard lumps of powder or if the solution is discoloured .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg , 10 mg and 20 mg . the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfORzia 100 mg oral powder in capsules with opening microstalline crosculose ( e460 ), colloidal anahydroussilica ( e463 ) and magnesium strearate ppalfor zia 300 mg oralpowder in sachet microCrystalline cellularose ( i464 ), colloid anhydrated silica ( i463 ), magnesium st
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used to treat sleeping problems in adults . the duration of treatment is one month . your doctor will decide how long you should continue treatment . if you have problems sleeping , talk to your doctor .
you should not be given zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if your doctor has told you that you have zerenea sleep apnoea syndrome ( which occurs for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes you to feel very weak , tired muscles , severe breathing or chest problems ). children and adolescents zere
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , you should take the capsule at least one hour before or one hour after food . you should not take more than one capsule in the morning . elderly people ( over 65 years of age ) if you suffer from mild to moderate liver problems , your doctor may increase your dose to one 5 mg capsule once a day . the capsule should be swallowed whole with a glass of water
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) very rare ( affects less than 1 users in 1 , 000 ) rare : very rare : not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 , 000 not known : frequency cannot been estimated from available data very rare
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : capsule contents : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . capsule shell : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide . printing ink : shellac , lecithin , simethicone , yellow iron oxide ( e172 ). what zereNE looks like and contents of the pack zeren 5 mg is an intense dark blue powder with a light brown cap
